id	sid	tid	token	lemma	pos
dpc-92	1	1	dermatology	dermatology	NOUN
dpc-92	1	2	:	:	PUNCT
dpc-92	1	3	practical	practical	ADJ
dpc-92	1	4	and	and	CCONJ
dpc-92	1	5	conceptual	conceptual	ADJ
dpc-92	1	6	research	research	NOUN
dpc-92	1	7	|	|	ADV
dpc-92	1	8	dermatol	dermatol	ADJ
dpc-92	1	9	pract	pract	NOUN
dpc-92	1	10	concept	concept	NOUN
dpc-92	1	11	2016;6(3):4	2016;6(3):4	NOUN
dpc-92	1	12	11	11	NUM
dpc-92	1	13	dermatology	dermatology	NOUN
dpc-92	1	14	practical	practical	ADJ
dpc-92	1	15	&	&	CCONJ
dpc-92	1	16	conceptual	conceptual	ADJ
dpc-92	1	17	www.derm101.com	www.derm101.com	X
dpc-92	1	18	introduction	introduction	NOUN
dpc-92	1	19	seborrheic	seborrheic	PROPN
dpc-92	1	20	dermatitis	dermatitis	NOUN
dpc-92	1	21	(	(	PUNCT
dpc-92	1	22	sd	sd	NOUN
dpc-92	1	23	)	)	PUNCT
dpc-92	1	24	,	,	PUNCT
dpc-92	1	25	a	a	DET
dpc-92	1	26	common	common	ADJ
dpc-92	1	27	skin	skin	NOUN
dpc-92	1	28	disorder	disorder	NOUN
dpc-92	1	29	that	that	PRON
dpc-92	1	30	typically	typically	ADV
dpc-92	1	31	presents	present	VERB
dpc-92	1	32	as	as	ADP
dpc-92	1	33	erythematous	erythematous	ADJ
dpc-92	1	34	plaques	plaque	NOUN
dpc-92	1	35	or	or	CCONJ
dpc-92	1	36	patches	patch	NOUN
dpc-92	1	37	and	and	CCONJ
dpc-92	1	38	can	can	AUX
dpc-92	1	39	vary	vary	VERB
dpc-92	1	40	from	from	ADP
dpc-92	1	41	mild	mild	ADJ
dpc-92	1	42	dandruff	dandruff	NOUN
dpc-92	1	43	to	to	ADP
dpc-92	1	44	dense	dense	ADJ
dpc-92	1	45	,	,	PUNCT
dpc-92	1	46	diffuse	diffuse	ADJ
dpc-92	1	47	,	,	PUNCT
dpc-92	1	48	adherent	adherent	ADJ
dpc-92	1	49	scale	scale	NOUN
dpc-92	1	50	affecting	affect	VERB
dpc-92	1	51	the	the	DET
dpc-92	1	52	areas	area	NOUN
dpc-92	1	53	where	where	SCONJ
dpc-92	1	54	sebaceous	sebaceous	ADJ
dpc-92	1	55	glands	gland	NOUN
dpc-92	1	56	are	be	AUX
dpc-92	1	57	prominent	prominent	ADJ
dpc-92	1	58	,	,	PUNCT
dpc-92	1	59	including	include	VERB
dpc-92	1	60	the	the	DET
dpc-92	1	61	scalp	scalp	NOUN
dpc-92	1	62	,	,	PUNCT
dpc-92	1	63	face	face	NOUN
dpc-92	1	64	and	and	CCONJ
dpc-92	1	65	chest	chest	NOUN
dpc-92	1	66	.	.	PUNCT
dpc-92	2	1	its	its	PRON
dpc-92	2	2	precise	precise	ADJ
dpc-92	2	3	etiology	etiology	NOUN
dpc-92	2	4	remains	remain	VERB
dpc-92	2	5	unknown	unknown	ADJ
dpc-92	2	6	,	,	PUNCT
dpc-92	2	7	though	though	SCONJ
dpc-92	2	8	it	it	PRON
dpc-92	2	9	is	be	AUX
dpc-92	2	10	associated	associate	VERB
dpc-92	2	11	with	with	ADP
dpc-92	2	12	genetic	genetic	ADJ
dpc-92	2	13	,	,	PUNCT
dpc-92	2	14	environmental	environmental	ADJ
dpc-92	2	15	,	,	PUNCT
dpc-92	2	16	and	and	CCONJ
dpc-92	2	17	general	general	ADJ
dpc-92	2	18	health	health	NOUN
dpc-92	2	19	factors	factor	NOUN
dpc-92	2	20	.	.	PUNCT
dpc-92	3	1	other	other	ADJ
dpc-92	3	2	important	important	ADJ
dpc-92	3	3	pathogenic	pathogenic	ADJ
dpc-92	3	4	factor	factor	NOUN
dpc-92	3	5	seems	seem	VERB
dpc-92	3	6	to	to	PART
dpc-92	3	7	be	be	AUX
dpc-92	3	8	malassezia	malassezia	NOUN
dpc-92	3	9	colonization	colonization	NOUN
dpc-92	3	10	.	.	PUNCT
dpc-92	4	1	its	its	PRON
dpc-92	4	2	role	role	NOUN
dpc-92	4	3	could	could	AUX
dpc-92	4	4	be	be	AUX
dpc-92	4	5	effect	effect	NOUN
dpc-92	4	6	of	of	ADP
dpc-92	4	7	itraconazole	itraconazole	NOUN
dpc-92	4	8	on	on	ADP
dpc-92	4	9	the	the	DET
dpc-92	4	10	quality	quality	NOUN
dpc-92	4	11	of	of	ADP
dpc-92	4	12	life	life	NOUN
dpc-92	4	13	in	in	ADP
dpc-92	4	14	patients	patient	NOUN
dpc-92	4	15	with	with	ADP
dpc-92	4	16	moderate	moderate	ADJ
dpc-92	4	17	to	to	ADP
dpc-92	4	18	severe	severe	ADJ
dpc-92	4	19	seborrheic	seborrheic	PROPN
dpc-92	4	20	dermatitis	dermatitis	NOUN
dpc-92	4	21	:	:	PUNCT
dpc-92	4	22	a	a	DET
dpc-92	4	23	randomized	randomized	ADJ
dpc-92	4	24	,	,	PUNCT
dpc-92	4	25	placebo	placebo	NOUN
dpc-92	4	26	-	-	PUNCT
dpc-92	4	27	controlled	control	VERB
dpc-92	4	28	trial	trial	NOUN
dpc-92	4	29	zaheer	zaheer	PROPN
dpc-92	4	30	abbas1	abbas1	PROPN
dpc-92	4	31	,	,	PUNCT
dpc-92	4	32	seyedeh	seyedeh	PROPN
dpc-92	4	33	z.	z.	PROPN
dpc-92	4	34	ghodsi1	ghodsi1	PROPN
dpc-92	4	35	,	,	PUNCT
dpc-92	4	36	robabeh	robabeh	NOUN
dpc-92	4	37	abedeni1	abedeni1	PROPN
dpc-92	4	38	1	1	NUM
dpc-92	4	39	department	department	NOUN
dpc-92	4	40	of	of	ADP
dpc-92	4	41	dermatology	dermatology	NOUN
dpc-92	4	42	,	,	PUNCT
dpc-92	4	43	razi	razi	PROPN
dpc-92	4	44	hospital	hospital	PROPN
dpc-92	4	45	,	,	PUNCT
dpc-92	4	46	tehran	tehran	PROPN
dpc-92	4	47	university	university	PROPN
dpc-92	4	48	of	of	ADP
dpc-92	4	49	medical	medical	ADJ
dpc-92	4	50	sciences	sciences	PROPN
dpc-92	4	51	,	,	PUNCT
dpc-92	4	52	tehran	tehran	PROPN
dpc-92	4	53	,	,	PUNCT
dpc-92	4	54	iran	iran	PROPN
dpc-92	4	55	key	key	ADJ
dpc-92	4	56	words	word	NOUN
dpc-92	4	57	:	:	PUNCT
dpc-92	4	58	itraconazole	itraconazole	NOUN
dpc-92	4	59	,	,	PUNCT
dpc-92	4	60	seborrheic	seborrheic	PROPN
dpc-92	4	61	dermatitis	dermatitis	NOUN
dpc-92	4	62	,	,	PUNCT
dpc-92	4	63	quality	quality	NOUN
dpc-92	4	64	of	of	ADP
dpc-92	4	65	life	life	NOUN
dpc-92	4	66	,	,	PUNCT
dpc-92	4	67	malassezia	malassezia	NOUN
dpc-92	4	68	citation	citation	NOUN
dpc-92	4	69	:	:	PUNCT
dpc-92	4	70	abbas	abbas	PROPN
dpc-92	4	71	z	z	PROPN
dpc-92	4	72	,	,	PUNCT
dpc-92	4	73	ghodsi	ghodsi	PROPN
dpc-92	4	74	sz	sz	PROPN
dpc-92	4	75	,	,	PUNCT
dpc-92	4	76	abedeni	abedeni	PROPN
dpc-92	4	77	r.	r.	PROPN
dpc-92	4	78	effect	effect	PROPN
dpc-92	4	79	of	of	ADP
dpc-92	4	80	itraconazole	itraconazole	NOUN
dpc-92	4	81	on	on	ADP
dpc-92	4	82	the	the	DET
dpc-92	4	83	quality	quality	NOUN
dpc-92	4	84	of	of	ADP
dpc-92	4	85	life	life	NOUN
dpc-92	4	86	in	in	ADP
dpc-92	4	87	patients	patient	NOUN
dpc-92	4	88	with	with	ADP
dpc-92	4	89	moderate	moderate	ADJ
dpc-92	4	90	to	to	ADP
dpc-92	4	91	severe	severe	ADJ
dpc-92	4	92	seborrheic	seborrheic	PROPN
dpc-92	4	93	dermatitis	dermatitis	NOUN
dpc-92	4	94	:	:	PUNCT
dpc-92	4	95	a	a	DET
dpc-92	4	96	randomized	randomized	ADJ
dpc-92	4	97	,	,	PUNCT
dpc-92	4	98	placebo	placebo	NOUN
dpc-92	4	99	-	-	PUNCT
dpc-92	4	100	controlled	control	VERB
dpc-92	4	101	trial	trial	NOUN
dpc-92	4	102	.	.	PUNCT
dpc-92	5	1	dermatol	dermatol	NOUN
dpc-92	5	2	pract	pract	PROPN
dpc-92	5	3	concept	concept	NOUN
dpc-92	5	4	2016;6(3):4	2016;6(3):4	PROPN
dpc-92	5	5	.	.	PUNCT
dpc-92	6	1	doi	doi	NOUN
dpc-92	6	2	:	:	PUNCT
dpc-92	6	3	10.5826	10.5826	NUM
dpc-92	6	4	/	/	SYM
dpc-92	6	5	dpc.0603a04	dpc.0603a04	NOUN
dpc-92	6	6	received	receive	VERB
dpc-92	6	7	:	:	PUNCT
dpc-92	6	8	november	november	PROPN
dpc-92	6	9	3	3	NUM
dpc-92	6	10	,	,	PUNCT
dpc-92	6	11	2015	2015	NUM
dpc-92	6	12	;	;	PUNCT
dpc-92	6	13	accepted	accept	VERB
dpc-92	6	14	:	:	PUNCT
dpc-92	6	15	april	april	PROPN
dpc-92	6	16	22	22	NUM
dpc-92	6	17	,	,	PUNCT
dpc-92	6	18	2016	2016	NUM
dpc-92	6	19	;	;	PUNCT
dpc-92	6	20	published	publish	VERB
dpc-92	6	21	:	:	PUNCT
dpc-92	6	22	july	july	PROPN
dpc-92	6	23	31	31	NUM
dpc-92	6	24	,	,	PUNCT
dpc-92	6	25	2016	2016	NUM
dpc-92	6	26	copyright	copyright	NOUN
dpc-92	6	27	:	:	PUNCT
dpc-92	6	28	©	©	PROPN
dpc-92	6	29	2016	2016	NUM
dpc-92	6	30	abbas	abbas	PROPN
dpc-92	6	31	et	et	PROPN
dpc-92	6	32	al	al	PROPN
dpc-92	6	33	.	.	PUNCT
dpc-92	7	1	this	this	PRON
dpc-92	7	2	is	be	AUX
dpc-92	7	3	an	an	DET
dpc-92	7	4	open	open	ADJ
dpc-92	7	5	-	-	PUNCT
dpc-92	7	6	access	access	NOUN
dpc-92	7	7	article	article	NOUN
dpc-92	7	8	distributed	distribute	VERB
dpc-92	7	9	under	under	ADP
dpc-92	7	10	the	the	DET
dpc-92	7	11	terms	term	NOUN
dpc-92	7	12	of	of	ADP
dpc-92	7	13	the	the	DET
dpc-92	7	14	creative	creative	ADJ
dpc-92	7	15	commons	common	NOUN
dpc-92	7	16	attribution	attribution	NOUN
dpc-92	7	17	license	license	NOUN
dpc-92	7	18	,	,	PUNCT
dpc-92	7	19	which	which	PRON
dpc-92	7	20	permits	permit	VERB
dpc-92	7	21	unrestricted	unrestricted	ADJ
dpc-92	7	22	use	use	NOUN
dpc-92	7	23	,	,	PUNCT
dpc-92	7	24	distribution	distribution	NOUN
dpc-92	7	25	,	,	PUNCT
dpc-92	7	26	and	and	CCONJ
dpc-92	7	27	reproduction	reproduction	NOUN
dpc-92	7	28	in	in	ADP
dpc-92	7	29	any	any	DET
dpc-92	7	30	medium	medium	NOUN
dpc-92	7	31	,	,	PUNCT
dpc-92	7	32	provided	provide	VERB
dpc-92	7	33	the	the	DET
dpc-92	7	34	original	original	ADJ
dpc-92	7	35	author	author	NOUN
dpc-92	7	36	and	and	CCONJ
dpc-92	7	37	source	source	NOUN
dpc-92	7	38	are	be	AUX
dpc-92	7	39	credited	credit	VERB
dpc-92	7	40	.	.	PUNCT
dpc-92	8	1	funding	funding	NOUN
dpc-92	8	2	:	:	PUNCT
dpc-92	8	3	none	none	NOUN
dpc-92	8	4	.	.	PUNCT
dpc-92	9	1	competing	compete	VERB
dpc-92	9	2	interests	interest	NOUN
dpc-92	9	3	:	:	PUNCT
dpc-92	9	4	the	the	DET
dpc-92	9	5	authors	author	NOUN
dpc-92	9	6	have	have	VERB
dpc-92	9	7	no	no	DET
dpc-92	9	8	conflicts	conflict	NOUN
dpc-92	9	9	of	of	ADP
dpc-92	9	10	interest	interest	NOUN
dpc-92	9	11	to	to	PART
dpc-92	9	12	disclose	disclose	VERB
dpc-92	9	13	.	.	PUNCT
dpc-92	10	1	all	all	DET
dpc-92	10	2	authors	author	NOUN
dpc-92	10	3	have	have	AUX
dpc-92	10	4	contributed	contribute	VERB
dpc-92	10	5	significantly	significantly	ADV
dpc-92	10	6	to	to	ADP
dpc-92	10	7	this	this	DET
dpc-92	10	8	publication	publication	NOUN
dpc-92	10	9	.	.	PUNCT
dpc-92	11	1	corresponding	correspond	VERB
dpc-92	11	2	author	author	NOUN
dpc-92	11	3	:	:	PUNCT
dpc-92	11	4	zaheer	zaheer	PROPN
dpc-92	11	5	abbas	abbas	PROPN
dpc-92	11	6	,	,	PUNCT
dpc-92	11	7	md	md	PROPN
dpc-92	11	8	,	,	PUNCT
dpc-92	11	9	department	department	PROPN
dpc-92	11	10	of	of	ADP
dpc-92	11	11	dermatology	dermatology	NOUN
dpc-92	11	12	,	,	PUNCT
dpc-92	11	13	razi	razi	PROPN
dpc-92	11	14	hospital	hospital	PROPN
dpc-92	11	15	,	,	PUNCT
dpc-92	11	16	tehran	tehran	PROPN
dpc-92	11	17	university	university	PROPN
dpc-92	11	18	of	of	ADP
dpc-92	11	19	medical	medical	PROPN
dpc-92	11	20	sciences	sciences	PROPN
dpc-92	11	21	and	and	CCONJ
dpc-92	11	22	health	health	NOUN
dpc-92	11	23	services	service	NOUN
dpc-92	11	24	,	,	PUNCT
dpc-92	11	25	vahdate	vahdate	VERB
dpc-92	11	26	eslami	eslami	ADJ
dpc-92	11	27	sq	sq	PROPN
dpc-92	11	28	.	.	PROPN
dpc-92	11	29	vahdate	vahdate	PROPN
dpc-92	11	30	eslami	eslami	PROPN
dpc-92	11	31	ave	ave	PROPN
dpc-92	11	32	.	.	PROPN
dpc-92	11	33	,	,	PUNCT
dpc-92	11	34	tehran	tehran	PROPN
dpc-92	11	35	,	,	PUNCT
dpc-92	11	36	iran	iran	PROPN
dpc-92	11	37	.	.	PUNCT
dpc-92	12	1	tel	tel	PROPN
dpc-92	12	2	.	.	PROPN
dpc-92	12	3	00989128432179	00989128432179	NUM
dpc-92	12	4	.	.	PUNCT
dpc-92	13	1	e	e	X
dpc-92	13	2	-	-	NOUN
dpc-92	13	3	mail	mail	NOUN
dpc-92	13	4	:	:	PUNCT
dpc-92	14	1	drzaheerabbas@yahoo.com	drzaheerabbas@yahoo.com	X
dpc-92	14	2	background	background	NOUN
dpc-92	14	3	:	:	PUNCT
dpc-92	14	4	few	few	ADJ
dpc-92	14	5	studies	study	NOUN
dpc-92	14	6	have	have	AUX
dpc-92	14	7	examined	examine	VERB
dpc-92	14	8	the	the	DET
dpc-92	14	9	effect	effect	NOUN
dpc-92	14	10	of	of	ADP
dpc-92	14	11	seborrheic	seborrheic	PROPN
dpc-92	14	12	dermatitis	dermatitis	NOUN
dpc-92	14	13	(	(	PUNCT
dpc-92	14	14	sd	sd	NOUN
dpc-92	14	15	)	)	PUNCT
dpc-92	14	16	and/or	and/or	CCONJ
dpc-92	14	17	its	its	PRON
dpc-92	14	18	consequent	consequent	ADJ
dpc-92	14	19	therapy	therapy	NOUN
dpc-92	14	20	on	on	ADP
dpc-92	14	21	a	a	DET
dpc-92	14	22	patient	patient	NOUN
dpc-92	14	23	’s	’s	PART
dpc-92	14	24	quality	quality	NOUN
dpc-92	14	25	of	of	ADP
dpc-92	14	26	life	life	NOUN
dpc-92	14	27	.	.	PUNCT
dpc-92	15	1	itraconazole	itraconazole	PROPN
dpc-92	15	2	has	have	AUX
dpc-92	15	3	been	be	AUX
dpc-92	15	4	suggested	suggest	VERB
dpc-92	15	5	as	as	ADP
dpc-92	15	6	an	an	DET
dpc-92	15	7	effective	effective	ADJ
dpc-92	15	8	therapy	therapy	NOUN
dpc-92	15	9	for	for	ADP
dpc-92	15	10	severe	severe	ADJ
dpc-92	15	11	sd	sd	NOUN
dpc-92	15	12	but	but	CCONJ
dpc-92	15	13	its	its	PRON
dpc-92	15	14	impact	impact	NOUN
dpc-92	15	15	on	on	ADP
dpc-92	15	16	quality	quality	NOUN
dpc-92	15	17	of	of	ADP
dpc-92	15	18	life	life	NOUN
dpc-92	15	19	(	(	PUNCT
dpc-92	15	20	qol	qol	NOUN
dpc-92	15	21	)	)	PUNCT
dpc-92	15	22	in	in	ADP
dpc-92	15	23	these	these	DET
dpc-92	15	24	patients	patient	NOUN
dpc-92	15	25	has	have	AUX
dpc-92	15	26	never	never	ADV
dpc-92	15	27	been	be	AUX
dpc-92	15	28	studied	study	VERB
dpc-92	15	29	before	before	ADV
dpc-92	15	30	.	.	PUNCT
dpc-92	16	1	objective	objective	NOUN
dpc-92	16	2	:	:	PUNCT
dpc-92	16	3	the	the	DET
dpc-92	16	4	study	study	NOUN
dpc-92	16	5	aimed	aim	VERB
dpc-92	16	6	to	to	PART
dpc-92	16	7	verify	verify	VERB
dpc-92	16	8	the	the	DET
dpc-92	16	9	efficacy	efficacy	NOUN
dpc-92	16	10	of	of	ADP
dpc-92	16	11	the	the	DET
dpc-92	16	12	itraconazole	itraconazole	NOUN
dpc-92	16	13	on	on	ADP
dpc-92	16	14	the	the	DET
dpc-92	16	15	quality	quality	NOUN
dpc-92	16	16	of	of	ADP
dpc-92	16	17	life	life	NOUN
dpc-92	16	18	in	in	ADP
dpc-92	16	19	patients	patient	NOUN
dpc-92	16	20	with	with	ADP
dpc-92	16	21	moderate	moderate	ADJ
dpc-92	16	22	to	to	ADP
dpc-92	16	23	severe	severe	ADJ
dpc-92	16	24	sd	sd	NOUN
dpc-92	16	25	.	.	PUNCT
dpc-92	17	1	methods	method	NOUN
dpc-92	17	2	:	:	PUNCT
dpc-92	17	3	a	a	DET
dpc-92	17	4	randomized	randomized	ADJ
dpc-92	17	5	,	,	PUNCT
dpc-92	17	6	double	double	ADJ
dpc-92	17	7	-	-	PUNCT
dpc-92	17	8	blind	blind	ADJ
dpc-92	17	9	,	,	PUNCT
dpc-92	17	10	placebo	placebo	NOUN
dpc-92	17	11	controlled	control	VERB
dpc-92	17	12	trial	trial	NOUN
dpc-92	17	13	was	be	AUX
dpc-92	17	14	planned	plan	VERB
dpc-92	17	15	to	to	PART
dpc-92	17	16	describe	describe	VERB
dpc-92	17	17	the	the	DET
dpc-92	17	18	effect	effect	NOUN
dpc-92	17	19	of	of	ADP
dpc-92	17	20	sd	sd	NOUN
dpc-92	17	21	per	per	X
dpc-92	17	22	se	se	X
dpc-92	17	23	on	on	ADP
dpc-92	17	24	qol	qol	NOUN
dpc-92	17	25	and	and	CCONJ
dpc-92	17	26	to	to	PART
dpc-92	17	27	determine	determine	VERB
dpc-92	17	28	the	the	DET
dpc-92	17	29	impact	impact	NOUN
dpc-92	17	30	of	of	ADP
dpc-92	17	31	oral	oral	ADJ
dpc-92	17	32	itraconazole	itraconazole	NOUN
dpc-92	17	33	or	or	CCONJ
dpc-92	17	34	placebo	placebo	NOUN
dpc-92	17	35	on	on	ADP
dpc-92	17	36	qol	qol	NOUN
dpc-92	17	37	of	of	ADP
dpc-92	17	38	sd	sd	ADP
dpc-92	17	39	patients	patient	NOUN
dpc-92	17	40	.	.	PUNCT
dpc-92	18	1	sixty	sixty	NUM
dpc-92	18	2	-	-	PUNCT
dpc-92	18	3	eight	eight	NUM
dpc-92	18	4	patients	patient	NOUN
dpc-92	18	5	with	with	ADP
dpc-92	18	6	moderate	moderate	ADJ
dpc-92	18	7	to	to	PART
dpc-92	18	8	severe	severe	ADJ
dpc-92	18	9	sd	sd	NOUN
dpc-92	18	10	participated	participate	VERB
dpc-92	18	11	in	in	ADP
dpc-92	18	12	the	the	DET
dpc-92	18	13	study	study	NOUN
dpc-92	18	14	to	to	PART
dpc-92	18	15	receive	receive	VERB
dpc-92	18	16	either	either	CCONJ
dpc-92	18	17	itraconazole	itraconazole	NOUN
dpc-92	18	18	or	or	CCONJ
dpc-92	18	19	placebo	placebo	NOUN
dpc-92	18	20	.	.	PUNCT
dpc-92	19	1	dermatology	dermatology	NOUN
dpc-92	19	2	life	life	NOUN
dpc-92	19	3	quality	quality	NOUN
dpc-92	19	4	index	index	NOUN
dpc-92	19	5	was	be	AUX
dpc-92	19	6	used	use	VERB
dpc-92	19	7	to	to	PART
dpc-92	19	8	evaluate	evaluate	VERB
dpc-92	19	9	their	their	PRON
dpc-92	19	10	quality	quality	NOUN
dpc-92	19	11	of	of	ADP
dpc-92	19	12	life	life	NOUN
dpc-92	19	13	before	before	ADP
dpc-92	19	14	and	and	CCONJ
dpc-92	19	15	after	after	ADP
dpc-92	19	16	treatment	treatment	NOUN
dpc-92	19	17	.	.	PUNCT
dpc-92	20	1	itraconazole	itraconazole	NOUN
dpc-92	20	2	200	200	NUM
dpc-92	20	3	mg	mg	PROPN
dpc-92	20	4	/	/	SYM
dpc-92	20	5	daily	daily	ADJ
dpc-92	20	6	or	or	CCONJ
dpc-92	20	7	placebo	placebo	NOUN
dpc-92	20	8	was	be	AUX
dpc-92	20	9	prescribed	prescribe	VERB
dpc-92	20	10	for	for	ADP
dpc-92	20	11	one	one	NUM
dpc-92	20	12	week	week	NOUN
dpc-92	20	13	and	and	CCONJ
dpc-92	20	14	then	then	ADV
dpc-92	20	15	the	the	DET
dpc-92	20	16	first	first	ADJ
dpc-92	20	17	two	two	NUM
dpc-92	20	18	days	day	NOUN
dpc-92	20	19	of	of	ADP
dpc-92	20	20	every	every	DET
dpc-92	20	21	month	month	NOUN
dpc-92	20	22	for	for	ADP
dpc-92	20	23	the	the	DET
dpc-92	20	24	following	follow	VERB
dpc-92	20	25	three	three	NUM
dpc-92	20	26	months	month	NOUN
dpc-92	20	27	.	.	PUNCT
dpc-92	21	1	fifty	fifty	NUM
dpc-92	21	2	-	-	PUNCT
dpc-92	21	3	seven	seven	NUM
dpc-92	21	4	patients	patient	NOUN
dpc-92	21	5	completed	complete	VERB
dpc-92	21	6	the	the	DET
dpc-92	21	7	study	study	NOUN
dpc-92	21	8	.	.	PUNCT
dpc-92	22	1	results	result	NOUN
dpc-92	22	2	:	:	PUNCT
dpc-92	22	3	significant	significant	ADJ
dpc-92	22	4	improvement	improvement	NOUN
dpc-92	22	5	was	be	AUX
dpc-92	22	6	observed	observe	VERB
dpc-92	22	7	in	in	ADP
dpc-92	22	8	qol	qol	NOUN
dpc-92	22	9	of	of	ADP
dpc-92	22	10	both	both	DET
dpc-92	22	11	itraconazole	itraconazole	NOUN
dpc-92	22	12	and	and	CCONJ
dpc-92	22	13	placebo	placebo	NOUN
dpc-92	22	14	groups	group	NOUN
dpc-92	22	15	,	,	PUNCT
dpc-92	22	16	but	but	CCONJ
dpc-92	22	17	itraconazole	itraconazole	PROPN
dpc-92	22	18	group	group	NOUN
dpc-92	22	19	showed	show	VERB
dpc-92	22	20	significantly	significantly	ADV
dpc-92	22	21	higher	high	ADJ
dpc-92	22	22	improvement	improvement	NOUN
dpc-92	22	23	as	as	SCONJ
dpc-92	22	24	compared	compare	VERB
dpc-92	22	25	to	to	ADP
dpc-92	22	26	placebo	placebo	NOUN
dpc-92	22	27	(	(	PUNCT
dpc-92	22	28	p=0.001	p=0.001	NUM
dpc-92	22	29	)	)	PUNCT
dpc-92	22	30	.	.	PUNCT
dpc-92	23	1	qol	qol	PROPN
dpc-92	23	2	was	be	AUX
dpc-92	23	3	impaired	impair	VERB
dpc-92	23	4	significantly	significantly	ADV
dpc-92	23	5	with	with	ADP
dpc-92	23	6	high	high	ADJ
dpc-92	23	7	disease	disease	NOUN
dpc-92	23	8	severity	severity	NOUN
dpc-92	23	9	(	(	PUNCT
dpc-92	23	10	p=0.002	p=0.002	NOUN
dpc-92	23	11	)	)	PUNCT
dpc-92	23	12	and	and	CCONJ
dpc-92	23	13	facial	facial	ADJ
dpc-92	23	14	involvement	involvement	NOUN
dpc-92	23	15	(	(	PUNCT
dpc-92	23	16	p=0.017	p=0.017	NUM
dpc-92	23	17	)	)	PUNCT
dpc-92	23	18	.	.	PUNCT
dpc-92	24	1	conclusions	conclusion	NOUN
dpc-92	24	2	:	:	PUNCT
dpc-92	24	3	itraconazole	itraconazole	PROPN
dpc-92	24	4	significantly	significantly	ADV
dpc-92	24	5	improves	improve	VERB
dpc-92	24	6	the	the	DET
dpc-92	24	7	qol	qol	NOUN
dpc-92	24	8	in	in	ADP
dpc-92	24	9	patients	patient	NOUN
dpc-92	24	10	with	with	ADP
dpc-92	24	11	moderate	moderate	ADJ
dpc-92	24	12	to	to	ADP
dpc-92	24	13	severe	severe	ADJ
dpc-92	24	14	sd	sd	NOUN
dpc-92	24	15	.	.	PUNCT
dpc-92	25	1	abstract	abstract	ADJ
dpc-92	25	2	mailto:drzaheerabbas@yahoo.com	mailto:drzaheerabbas@yahoo.com	PROPN
dpc-92	25	3	12	12	NUM
dpc-92	26	1	research	research	NOUN
dpc-92	26	2	|	|	ADV
dpc-92	26	3	dermatol	dermatol	NOUN
dpc-92	26	4	pract	pract	NOUN
dpc-92	26	5	concept	concept	NOUN
dpc-92	26	6	2016;6(3):4	2016;6(3):4	NOUN
dpc-92	26	7	methods	method	NOUN
dpc-92	26	8	this	this	PRON
dpc-92	26	9	was	be	AUX
dpc-92	26	10	a	a	DET
dpc-92	26	11	randomized	randomized	ADJ
dpc-92	26	12	placebo	placebo	NOUN
dpc-92	26	13	controlled	control	VERB
dpc-92	26	14	,	,	PUNCT
dpc-92	26	15	double	double	ADJ
dpc-92	26	16	-	-	PUNCT
dpc-92	26	17	blind	blind	ADJ
dpc-92	26	18	trial	trial	NOUN
dpc-92	26	19	carried	carry	VERB
dpc-92	26	20	out	out	ADP
dpc-92	26	21	with	with	ADP
dpc-92	26	22	patients	patient	NOUN
dpc-92	26	23	attending	attend	VERB
dpc-92	26	24	the	the	DET
dpc-92	26	25	outpatient	outpatient	NOUN
dpc-92	26	26	ward	ward	NOUN
dpc-92	26	27	of	of	ADP
dpc-92	26	28	the	the	DET
dpc-92	26	29	dermatology	dermatology	NOUN
dpc-92	26	30	department	department	NOUN
dpc-92	26	31	at	at	ADP
dpc-92	26	32	the	the	DET
dpc-92	26	33	razi	razi	PROPN
dpc-92	26	34	hospital	hospital	PROPN
dpc-92	26	35	tehran	tehran	PROPN
dpc-92	26	36	,	,	PUNCT
dpc-92	26	37	between	between	ADP
dpc-92	26	38	june	june	PROPN
dpc-92	26	39	2012	2012	NUM
dpc-92	26	40	and	and	CCONJ
dpc-92	26	41	march	march	PROPN
dpc-92	26	42	2014	2014	NUM
dpc-92	26	43	.	.	PUNCT
dpc-92	27	1	patients	patient	NOUN
dpc-92	27	2	were	be	AUX
dpc-92	27	3	informed	inform	VERB
dpc-92	27	4	clearly	clearly	ADV
dpc-92	27	5	and	and	CCONJ
dpc-92	27	6	understandably	understandably	ADV
dpc-92	27	7	about	about	ADP
dpc-92	27	8	the	the	DET
dpc-92	27	9	possible	possible	ADJ
dpc-92	27	10	risks	risk	NOUN
dpc-92	27	11	or	or	CCONJ
dpc-92	27	12	benefits	benefit	NOUN
dpc-92	27	13	of	of	ADP
dpc-92	27	14	the	the	DET
dpc-92	27	15	trial	trial	NOUN
dpc-92	27	16	and	and	CCONJ
dpc-92	27	17	informed	informed	ADJ
dpc-92	27	18	consent	consent	NOUN
dpc-92	27	19	was	be	AUX
dpc-92	27	20	provided	provide	VERB
dpc-92	27	21	by	by	ADP
dpc-92	27	22	each	each	DET
dpc-92	27	23	patient	patient	NOUN
dpc-92	27	24	included	include	VERB
dpc-92	27	25	in	in	ADP
dpc-92	27	26	the	the	DET
dpc-92	27	27	study	study	NOUN
dpc-92	27	28	.	.	PUNCT
dpc-92	28	1	the	the	DET
dpc-92	28	2	approval	approval	NOUN
dpc-92	28	3	of	of	ADP
dpc-92	28	4	the	the	DET
dpc-92	28	5	study	study	NOUN
dpc-92	28	6	was	be	AUX
dpc-92	28	7	obtained	obtain	VERB
dpc-92	28	8	by	by	ADP
dpc-92	28	9	the	the	DET
dpc-92	28	10	local	local	ADJ
dpc-92	28	11	and	and	CCONJ
dpc-92	28	12	university	university	NOUN
dpc-92	28	13	ethics	ethic	NOUN
dpc-92	28	14	committees	committee	NOUN
dpc-92	28	15	and	and	CCONJ
dpc-92	28	16	performed	perform	VERB
dpc-92	28	17	in	in	ADP
dpc-92	28	18	accordance	accordance	NOUN
dpc-92	28	19	with	with	ADP
dpc-92	28	20	the	the	DET
dpc-92	28	21	helsinki	helsinki	PROPN
dpc-92	28	22	declaration	declaration	NOUN
dpc-92	28	23	of	of	ADP
dpc-92	28	24	1964	1964	NUM
dpc-92	28	25	,	,	PUNCT
dpc-92	28	26	as	as	SCONJ
dpc-92	28	27	revised	revise	VERB
dpc-92	28	28	in	in	ADP
dpc-92	28	29	2013	2013	NUM
dpc-92	28	30	.	.	PUNCT
dpc-92	29	1	the	the	DET
dpc-92	29	2	study	study	NOUN
dpc-92	29	3	design	design	NOUN
dpc-92	29	4	is	be	AUX
dpc-92	29	5	summarized	summarize	VERB
dpc-92	29	6	in	in	ADP
dpc-92	29	7	figure	figure	NOUN
dpc-92	29	8	1	1	NUM
dpc-92	29	9	.	.	PUNCT
dpc-92	30	1	inclusion	inclusion	NOUN
dpc-92	30	2	criteria	criterion	NOUN
dpc-92	30	3	were	be	AUX
dpc-92	30	4	clinical	clinical	ADJ
dpc-92	30	5	diagnosis	diagnosis	NOUN
dpc-92	30	6	of	of	ADP
dpc-92	30	7	sd	sd	NOUN
dpc-92	30	8	made	make	VERB
dpc-92	30	9	by	by	ADP
dpc-92	30	10	a	a	DET
dpc-92	30	11	dermatologist	dermatologist	NOUN
dpc-92	30	12	,	,	PUNCT
dpc-92	30	13	moderate	moderate	ADJ
dpc-92	30	14	to	to	ADP
dpc-92	30	15	severe	severe	ADJ
dpc-92	30	16	sd	sd	ADP
dpc-92	30	17	(	(	PUNCT
dpc-92	30	18	seborrheic	seborrheic	PROPN
dpc-92	30	19	dermatitis	dermatitis	NOUN
dpc-92	30	20	area	area	NOUN
dpc-92	30	21	severity	severity	NOUN
dpc-92	30	22	index	index	NOUN
dpc-92	30	23	[	[	X
dpc-92	30	24	sdasi	sdasi	X
dpc-92	30	25	]	]	X
dpc-92	30	26	=	=	SYM
dpc-92	30	27	4	4	NUM
dpc-92	30	28	plus	plus	CCONJ
dpc-92	30	29	:	:	PUNCT
dpc-92	30	30	≥3	≥3	ADJ
dpc-92	30	31	anatomical	anatomical	ADJ
dpc-92	30	32	sites	site	NOUN
dpc-92	30	33	involved	involve	VERB
dpc-92	30	34	and/or	and/or	CCONJ
dpc-92	30	35	recurrent	recurrent	ADJ
dpc-92	30	36	sd	sd	NOUN
dpc-92	30	37	and/or	and/or	CCONJ
dpc-92	30	38	disease	disease	NOUN
dpc-92	30	39	unresponsive	unresponsive	ADJ
dpc-92	30	40	to	to	ADP
dpc-92	30	41	conventional	conventional	ADJ
dpc-92	30	42	topical	topical	ADJ
dpc-92	30	43	therapy	therapy	NOUN
dpc-92	30	44	)	)	PUNCT
dpc-92	30	45	and	and	CCONJ
dpc-92	30	46	age	age	NOUN
dpc-92	30	47	≥18	≥18	NUM
dpc-92	30	48	years	year	NOUN
dpc-92	30	49	.	.	PUNCT
dpc-92	31	1	exclusion	exclusion	NOUN
dpc-92	31	2	criteria	criterion	NOUN
dpc-92	31	3	included	include	VERB
dpc-92	31	4	the	the	DET
dpc-92	31	5	following	following	NOUN
dpc-92	31	6	:	:	PUNCT
dpc-92	31	7	any	any	DET
dpc-92	31	8	concomitant	concomitant	ADJ
dpc-92	31	9	skin	skin	NOUN
dpc-92	31	10	disease	disease	NOUN
dpc-92	31	11	(	(	PUNCT
dpc-92	31	12	e.g.	e.g.	ADV
dpc-92	31	13	acne	acne	NOUN
dpc-92	31	14	,	,	PUNCT
dpc-92	31	15	rosacea	rosacea	NOUN
dpc-92	31	16	,	,	PUNCT
dpc-92	31	17	contact	contact	NOUN
dpc-92	31	18	dermatitis	dermatitis	NOUN
dpc-92	31	19	)	)	PUNCT
dpc-92	31	20	or	or	CCONJ
dpc-92	31	21	hiv+/aids	hiv+/aid	NOUN
dpc-92	31	22	,	,	PUNCT
dpc-92	31	23	recent	recent	ADJ
dpc-92	31	24	use	use	NOUN
dpc-92	31	25	of	of	ADP
dpc-92	31	26	antiseborrheic	antiseborrheic	VERB
dpc-92	31	27	treatment	treatment	NOUN
dpc-92	31	28	(	(	PUNCT
dpc-92	31	29	2	2	NUM
dpc-92	31	30	weeks	week	NOUN
dpc-92	31	31	for	for	ADP
dpc-92	31	32	topical	topical	ADJ
dpc-92	31	33	and	and	CCONJ
dpc-92	31	34	4	4	NUM
dpc-92	31	35	weeks	week	NOUN
dpc-92	31	36	for	for	ADP
dpc-92	31	37	systemic	systemic	ADJ
dpc-92	31	38	therapy	therapy	NOUN
dpc-92	31	39	)	)	PUNCT
dpc-92	31	40	,	,	PUNCT
dpc-92	31	41	history	history	NOUN
dpc-92	31	42	of	of	ADP
dpc-92	31	43	allergy	allergy	NOUN
dpc-92	31	44	to	to	ADP
dpc-92	31	45	azoles	azole	NOUN
dpc-92	31	46	,	,	PUNCT
dpc-92	31	47	renal	renal	ADJ
dpc-92	31	48	,	,	PUNCT
dpc-92	31	49	liver	liver	NOUN
dpc-92	31	50	or	or	CCONJ
dpc-92	31	51	cardiac	cardiac	ADJ
dpc-92	31	52	disease	disease	NOUN
dpc-92	31	53	,	,	PUNCT
dpc-92	31	54	patients	patient	NOUN
dpc-92	31	55	using	use	VERB
dpc-92	31	56	drugs	drug	NOUN
dpc-92	31	57	interacting	interact	VERB
dpc-92	31	58	with	with	ADP
dpc-92	31	59	itraconazole	itraconazole	NOUN
dpc-92	31	60	(	(	PUNCT
dpc-92	31	61	e.g.	e.g.	ADV
dpc-92	31	62	,	,	PUNCT
dpc-92	31	63	cyclosporine	cyclosporine	NOUN
dpc-92	31	64	,	,	PUNCT
dpc-92	31	65	isoniazide	isoniazide	ADJ
dpc-92	31	66	,	,	PUNCT
dpc-92	31	67	omeprazole	omeprazole	NOUN
dpc-92	31	68	,	,	PUNCT
dpc-92	31	69	warfarin	warfarin	NOUN
dpc-92	31	70	,	,	PUNCT
dpc-92	31	71	statins	statins	PROPN
dpc-92	31	72	)	)	PUNCT
dpc-92	31	73	,	,	PUNCT
dpc-92	31	74	and	and	CCONJ
dpc-92	31	75	pregnant	pregnant	ADJ
dpc-92	31	76	/	/	SYM
dpc-92	31	77	lactating	lactate	VERB
dpc-92	31	78	women	woman	NOUN
dpc-92	31	79	.	.	PUNCT
dpc-92	32	1	both	both	DET
dpc-92	32	2	itraconazole	itraconazole	NOUN
dpc-92	32	3	supported	support	VERB
dpc-92	32	4	by	by	ADP
dpc-92	32	5	the	the	DET
dpc-92	32	6	positive	positive	ADJ
dpc-92	32	7	correlation	correlation	NOUN
dpc-92	32	8	between	between	ADP
dpc-92	32	9	yeast	yeast	NOUN
dpc-92	32	10	density	density	NOUN
dpc-92	32	11	on	on	ADP
dpc-92	32	12	the	the	DET
dpc-92	32	13	skin	skin	NOUN
dpc-92	32	14	and	and	CCONJ
dpc-92	32	15	the	the	DET
dpc-92	32	16	severity	severity	NOUN
dpc-92	32	17	of	of	ADP
dpc-92	32	18	sd	sd	NOUN
dpc-92	32	19	and	and	CCONJ
dpc-92	32	20	a	a	DET
dpc-92	32	21	high	high	ADJ
dpc-92	32	22	efficacy	efficacy	NOUN
dpc-92	32	23	of	of	ADP
dpc-92	32	24	antifungal	antifungal	ADJ
dpc-92	32	25	agents	agent	NOUN
dpc-92	32	26	in	in	ADP
dpc-92	32	27	the	the	DET
dpc-92	32	28	treatment	treatment	NOUN
dpc-92	32	29	of	of	ADP
dpc-92	32	30	this	this	DET
dpc-92	32	31	disorder	disorder	NOUN
dpc-92	32	32	[	[	X
dpc-92	32	33	1,2,3	1,2,3	NOUN
dpc-92	32	34	]	]	PUNCT
dpc-92	32	35	.	.	PUNCT
dpc-92	33	1	while	while	SCONJ
dpc-92	33	2	sd	sd	NOUN
dpc-92	33	3	rarely	rarely	ADV
dpc-92	33	4	causes	cause	VERB
dpc-92	33	5	serious	serious	ADJ
dpc-92	33	6	complications	complication	NOUN
dpc-92	33	7	,	,	PUNCT
dpc-92	33	8	it	it	PRON
dpc-92	33	9	almost	almost	ADV
dpc-92	33	10	always	always	ADV
dpc-92	33	11	leads	lead	VERB
dpc-92	33	12	to	to	ADP
dpc-92	33	13	marked	mark	VERB
dpc-92	33	14	aesthetic	aesthetic	ADJ
dpc-92	33	15	deterioration	deterioration	NOUN
dpc-92	33	16	and	and	CCONJ
dpc-92	33	17	psychological	psychological	ADJ
dpc-92	33	18	distress	distress	NOUN
dpc-92	33	19	due	due	ADP
dpc-92	33	20	to	to	ADP
dpc-92	33	21	its	its	PRON
dpc-92	33	22	chronic	chronic	NOUN
dpc-92	33	23	and	and	CCONJ
dpc-92	33	24	relapsing	relapse	VERB
dpc-92	33	25	nature	nature	NOUN
dpc-92	33	26	.	.	PUNCT
dpc-92	34	1	despite	despite	SCONJ
dpc-92	34	2	high	high	ADJ
dpc-92	34	3	frequency	frequency	NOUN
dpc-92	34	4	of	of	ADP
dpc-92	34	5	sd	sd	NOUN
dpc-92	34	6	,	,	PUNCT
dpc-92	34	7	surprisingly	surprisingly	ADV
dpc-92	34	8	,	,	PUNCT
dpc-92	34	9	only	only	ADV
dpc-92	34	10	few	few	ADJ
dpc-92	34	11	studies	study	NOUN
dpc-92	34	12	have	have	AUX
dpc-92	34	13	examined	examine	VERB
dpc-92	34	14	the	the	DET
dpc-92	34	15	effect	effect	NOUN
dpc-92	34	16	of	of	ADP
dpc-92	34	17	sd	sd	NOUN
dpc-92	34	18	on	on	ADP
dpc-92	34	19	quality	quality	NOUN
dpc-92	34	20	of	of	ADP
dpc-92	34	21	life	life	NOUN
dpc-92	34	22	(	(	PUNCT
dpc-92	34	23	qol	qol	NOUN
dpc-92	34	24	)	)	PUNCT
dpc-92	35	1	[	[	X
dpc-92	35	2	4	4	NUM
dpc-92	35	3	-	-	SYM
dpc-92	35	4	6	6	NUM
dpc-92	35	5	]	]	PUNCT
dpc-92	35	6	.	.	PUNCT
dpc-92	36	1	although	although	SCONJ
dpc-92	36	2	the	the	DET
dpc-92	36	3	topical	topical	ADJ
dpc-92	36	4	treatment	treatment	NOUN
dpc-92	36	5	of	of	ADP
dpc-92	36	6	sd	sd	NOUN
dpc-92	36	7	with	with	ADP
dpc-92	36	8	corticosteroids	corticosteroid	NOUN
dpc-92	36	9	or	or	CCONJ
dpc-92	36	10	antifungals	antifungal	NOUN
dpc-92	36	11	is	be	AUX
dpc-92	36	12	effective	effective	ADJ
dpc-92	36	13	,	,	PUNCT
dpc-92	36	14	there	there	PRON
dpc-92	36	15	is	be	VERB
dpc-92	36	16	a	a	DET
dpc-92	36	17	high	high	ADJ
dpc-92	36	18	risk	risk	NOUN
dpc-92	36	19	of	of	ADP
dpc-92	36	20	relapse	relapse	NOUN
dpc-92	36	21	and	and	CCONJ
dpc-92	36	22	poor	poor	ADJ
dpc-92	36	23	patient	patient	ADJ
dpc-92	36	24	compliance	compliance	NOUN
dpc-92	36	25	[	[	X
dpc-92	36	26	7	7	NUM
dpc-92	36	27	]	]	PUNCT
dpc-92	36	28	,	,	PUNCT
dpc-92	36	29	and	and	CCONJ
dpc-92	36	30	therefore	therefore	ADV
dpc-92	36	31	in	in	ADP
dpc-92	36	32	some	some	DET
dpc-92	36	33	cases	case	NOUN
dpc-92	36	34	it	it	PRON
dpc-92	36	35	is	be	AUX
dpc-92	36	36	necessary	necessary	ADJ
dpc-92	36	37	to	to	PART
dpc-92	36	38	resort	resort	VERB
dpc-92	36	39	to	to	ADP
dpc-92	36	40	systemic	systemic	ADJ
dpc-92	36	41	antifungals	antifungal	NOUN
dpc-92	36	42	,	,	PUNCT
dpc-92	36	43	especially	especially	ADV
dpc-92	36	44	in	in	ADP
dpc-92	36	45	severe	severe	ADJ
dpc-92	36	46	disease	disease	NOUN
dpc-92	36	47	.	.	PUNCT
dpc-92	37	1	various	various	ADJ
dpc-92	37	2	oral	oral	ADJ
dpc-92	37	3	antifungals	antifungal	NOUN
dpc-92	37	4	have	have	AUX
dpc-92	37	5	been	be	AUX
dpc-92	37	6	used	use	VERB
dpc-92	37	7	to	to	PART
dpc-92	37	8	control	control	VERB
dpc-92	37	9	sd	sd	ADP
dpc-92	37	10	with	with	ADP
dpc-92	37	11	variable	variable	ADJ
dpc-92	37	12	success	success	NOUN
dpc-92	37	13	rates	rate	NOUN
dpc-92	37	14	.	.	PUNCT
dpc-92	38	1	among	among	ADP
dpc-92	38	2	them	they	PRON
dpc-92	38	3	,	,	PUNCT
dpc-92	38	4	itraconazole	itraconazole	PROPN
dpc-92	38	5	was	be	AUX
dpc-92	38	6	the	the	DET
dpc-92	38	7	most	most	ADV
dpc-92	38	8	frequently	frequently	ADV
dpc-92	38	9	reported	report	VERB
dpc-92	38	10	oral	oral	ADJ
dpc-92	38	11	treatment	treatment	NOUN
dpc-92	38	12	particularly	particularly	ADV
dpc-92	38	13	for	for	ADP
dpc-92	38	14	severe	severe	ADJ
dpc-92	38	15	sd	sd	NOUN
dpc-92	38	16	[	[	X
dpc-92	38	17	8	8	NUM
dpc-92	38	18	]	]	PUNCT
dpc-92	38	19	,	,	PUNCT
dpc-92	38	20	but	but	CCONJ
dpc-92	38	21	therapeutic	therapeutic	ADJ
dpc-92	38	22	efficacy	efficacy	NOUN
dpc-92	38	23	was	be	AUX
dpc-92	38	24	evaluated	evaluate	VERB
dpc-92	38	25	only	only	ADV
dpc-92	38	26	by	by	ADP
dpc-92	38	27	clinical	clinical	ADJ
dpc-92	38	28	signs	sign	NOUN
dpc-92	38	29	and	and	CCONJ
dpc-92	38	30	symptoms	symptom	NOUN
dpc-92	38	31	in	in	ADP
dpc-92	38	32	previous	previous	ADJ
dpc-92	38	33	studies	study	NOUN
dpc-92	38	34	[	[	X
dpc-92	38	35	7,9	7,9	NUM
dpc-92	38	36	-	-	SYM
dpc-92	38	37	11	11	NUM
dpc-92	38	38	]	]	PUNCT
dpc-92	38	39	.	.	PUNCT
dpc-92	39	1	assessing	assess	VERB
dpc-92	39	2	qol	qol	NOUN
dpc-92	39	3	can	can	AUX
dpc-92	39	4	help	help	VERB
dpc-92	39	5	in	in	ADP
dpc-92	39	6	providing	provide	VERB
dpc-92	39	7	patients	patient	NOUN
dpc-92	39	8	better	well	ADJ
dpc-92	39	9	service	service	NOUN
dpc-92	39	10	,	,	PUNCT
dpc-92	39	11	by	by	ADP
dpc-92	39	12	acknowledging	acknowledge	VERB
dpc-92	39	13	their	their	PRON
dpc-92	39	14	real	real	ADJ
dpc-92	39	15	needs	need	NOUN
dpc-92	39	16	and	and	CCONJ
dpc-92	39	17	interfering	interfere	VERB
dpc-92	39	18	with	with	ADP
dpc-92	39	19	treatment	treatment	NOUN
dpc-92	39	20	decisions	decision	NOUN
dpc-92	39	21	.	.	PUNCT
dpc-92	40	1	because	because	SCONJ
dpc-92	40	2	qol	qol	NOUN
dpc-92	40	3	is	be	AUX
dpc-92	40	4	a	a	DET
dpc-92	40	5	very	very	ADV
dpc-92	40	6	important	important	ADJ
dpc-92	40	7	aspect	aspect	NOUN
dpc-92	40	8	in	in	ADP
dpc-92	40	9	health	health	NOUN
dpc-92	40	10	and	and	CCONJ
dpc-92	40	11	no	no	DET
dpc-92	40	12	study	study	NOUN
dpc-92	40	13	exists	exist	VERB
dpc-92	40	14	in	in	ADP
dpc-92	40	15	the	the	DET
dpc-92	40	16	literature	literature	NOUN
dpc-92	40	17	which	which	PRON
dpc-92	40	18	assess	assess	VERB
dpc-92	40	19	the	the	DET
dpc-92	40	20	effect	effect	NOUN
dpc-92	40	21	of	of	ADP
dpc-92	40	22	treatment	treatment	NOUN
dpc-92	40	23	on	on	ADP
dpc-92	40	24	qol	qol	NOUN
dpc-92	40	25	in	in	ADP
dpc-92	40	26	sd	sd	ADP
dpc-92	40	27	patients	patient	NOUN
dpc-92	40	28	,	,	PUNCT
dpc-92	40	29	this	this	PRON
dpc-92	40	30	randomized	randomize	VERB
dpc-92	40	31	controlled	control	VERB
dpc-92	40	32	trial	trial	NOUN
dpc-92	40	33	was	be	AUX
dpc-92	40	34	set	set	VERB
dpc-92	40	35	up	up	ADP
dpc-92	40	36	to	to	PART
dpc-92	40	37	determine	determine	VERB
dpc-92	40	38	the	the	DET
dpc-92	40	39	impact	impact	NOUN
dpc-92	40	40	of	of	ADP
dpc-92	40	41	oral	oral	ADJ
dpc-92	40	42	itraconazole	itraconazole	NOUN
dpc-92	40	43	on	on	ADP
dpc-92	40	44	qol	qol	PROPN
dpc-92	40	45	in	in	ADP
dpc-92	40	46	patients	patient	NOUN
dpc-92	40	47	with	with	ADP
dpc-92	40	48	moderate	moderate	ADJ
dpc-92	40	49	to	to	ADP
dpc-92	40	50	severe	severe	ADJ
dpc-92	40	51	sd	sd	NOUN
dpc-92	40	52	.	.	PUNCT
dpc-92	41	1	figure	figure	NOUN
dpc-92	41	2	1	1	NUM
dpc-92	41	3	.	.	PUNCT
dpc-92	42	1	flow	flow	NOUN
dpc-92	42	2	diagram	diagram	NOUN
dpc-92	42	3	of	of	ADP
dpc-92	42	4	the	the	DET
dpc-92	42	5	study	study	NOUN
dpc-92	42	6	.	.	PUNCT
dpc-92	43	1	[	[	X
dpc-92	43	2	copyright	copyright	NOUN
dpc-92	43	3	:	:	PUNCT
dpc-92	43	4	©	©	PROPN
dpc-92	43	5	2016	2016	NUM
dpc-92	43	6	abbas	abbas	PROPN
dpc-92	43	7	et	et	PROPN
dpc-92	43	8	al	al	PROPN
dpc-92	43	9	.	.	PROPN
dpc-92	43	10	]	]	PUNCT
dpc-92	44	1	research	research	NOUN
dpc-92	44	2	|	|	ADV
dpc-92	44	3	dermatol	dermatol	NOUN
dpc-92	44	4	pract	pract	NOUN
dpc-92	44	5	concept	concept	NOUN
dpc-92	44	6	2016;6(3):4	2016;6(3):4	PROPN
dpc-92	44	7	13	13	NUM
dpc-92	44	8	sone	sone	NOUN
dpc-92	44	9	ointment	ointment	NOUN
dpc-92	44	10	once	once	ADV
dpc-92	44	11	daily	daily	ADV
dpc-92	44	12	and	and	CCONJ
dpc-92	44	13	2	2	NUM
dpc-92	44	14	%	%	NOUN
dpc-92	44	15	ketoconazole	ketoconazole	NOUN
dpc-92	44	16	cream	cream	NOUN
dpc-92	44	17	twice	twice	ADV
dpc-92	44	18	daily	daily	ADV
dpc-92	44	19	plus	plus	CCONJ
dpc-92	44	20	either	either	CCONJ
dpc-92	44	21	oral	oral	ADJ
dpc-92	44	22	itraconazole	itraconazole	NOUN
dpc-92	44	23	200	200	NUM
dpc-92	44	24	mg	mg	NUM
dpc-92	44	25	/	/	SYM
dpc-92	44	26	day	day	NOUN
dpc-92	44	27	or	or	CCONJ
dpc-92	44	28	oral	oral	ADJ
dpc-92	44	29	placebo	placebo	NOUN
dpc-92	44	30	was	be	AUX
dpc-92	44	31	prescribed	prescribe	VERB
dpc-92	44	32	for	for	ADP
dpc-92	44	33	one	one	NUM
dpc-92	44	34	week	week	NOUN
dpc-92	44	35	.	.	PUNCT
dpc-92	45	1	patients	patient	NOUN
dpc-92	45	2	were	be	AUX
dpc-92	45	3	advised	advise	VERB
dpc-92	45	4	to	to	PART
dpc-92	45	5	apply	apply	VERB
dpc-92	45	6	topical	topical	ADJ
dpc-92	45	7	therapy	therapy	NOUN
dpc-92	45	8	on	on	ADP
dpc-92	45	9	the	the	DET
dpc-92	45	10	areas	area	NOUN
dpc-92	45	11	involved	involve	VERB
dpc-92	45	12	.	.	PUNCT
dpc-92	46	1	topical	topical	ADJ
dpc-92	46	2	treatment	treatment	NOUN
dpc-92	46	3	was	be	AUX
dpc-92	46	4	included	include	VERB
dpc-92	46	5	in	in	ADP
dpc-92	46	6	the	the	DET
dpc-92	46	7	study	study	NOUN
dpc-92	46	8	for	for	ADP
dpc-92	46	9	ethical	ethical	ADJ
dpc-92	46	10	issues	issue	NOUN
dpc-92	46	11	.	.	PUNCT
dpc-92	47	1	in	in	ADP
dpc-92	47	2	the	the	DET
dpc-92	47	3	second	second	ADJ
dpc-92	47	4	phase	phase	NOUN
dpc-92	47	5	(	(	PUNCT
dpc-92	47	6	one	one	NUM
dpc-92	47	7	month	month	NOUN
dpc-92	47	8	after	after	ADP
dpc-92	47	9	initial	initial	ADJ
dpc-92	47	10	treatment	treatment	NOUN
dpc-92	47	11	)	)	PUNCT
dpc-92	47	12	,	,	PUNCT
dpc-92	47	13	which	which	PRON
dpc-92	47	14	was	be	AUX
dpc-92	47	15	maintenance	maintenance	NOUN
dpc-92	47	16	period	period	NOUN
dpc-92	47	17	,	,	PUNCT
dpc-92	47	18	oral	oral	ADJ
dpc-92	47	19	itraconazole	itraconazole	NOUN
dpc-92	47	20	200	200	NUM
dpc-92	47	21	mg	mg	NUM
dpc-92	47	22	/	/	SYM
dpc-92	47	23	day	day	NOUN
dpc-92	47	24	or	or	CCONJ
dpc-92	47	25	oral	oral	ADJ
dpc-92	47	26	placebo	placebo	NOUN
dpc-92	47	27	was	be	AUX
dpc-92	47	28	given	give	VERB
dpc-92	47	29	on	on	ADP
dpc-92	47	30	the	the	DET
dpc-92	47	31	first	first	ADJ
dpc-92	47	32	two	two	NUM
dpc-92	47	33	days	day	NOUN
dpc-92	47	34	of	of	ADP
dpc-92	47	35	every	every	DET
dpc-92	47	36	month	month	NOUN
dpc-92	47	37	(	(	PUNCT
dpc-92	47	38	400	400	NUM
dpc-92	47	39	mg	mg	NUM
dpc-92	47	40	/	/	SYM
dpc-92	47	41	month	month	NOUN
dpc-92	47	42	)	)	PUNCT
dpc-92	47	43	for	for	ADP
dpc-92	47	44	three	three	NUM
dpc-92	47	45	months	month	NOUN
dpc-92	47	46	.	.	PUNCT
dpc-92	48	1	no	no	DET
dpc-92	48	2	other	other	ADJ
dpc-92	48	3	topical	topical	ADJ
dpc-92	48	4	treatment	treatment	NOUN
dpc-92	48	5	,	,	PUNCT
dpc-92	48	6	including	include	VERB
dpc-92	48	7	therapeutic	therapeutic	ADJ
dpc-92	48	8	shampoos	shampoo	NOUN
dpc-92	48	9	(	(	PUNCT
dpc-92	48	10	except	except	SCONJ
dpc-92	48	11	moisturizers	moisturizer	NOUN
dpc-92	48	12	)	)	PUNCT
dpc-92	48	13	or	or	CCONJ
dpc-92	48	14	oral	oral	ADJ
dpc-92	48	15	medications	medication	NOUN
dpc-92	48	16	,	,	PUNCT
dpc-92	48	17	was	be	AUX
dpc-92	48	18	allowed	allow	VERB
dpc-92	48	19	during	during	ADP
dpc-92	48	20	this	this	DET
dpc-92	48	21	study	study	NOUN
dpc-92	48	22	period	period	NOUN
dpc-92	48	23	.	.	PUNCT
dpc-92	49	1	during	during	ADP
dpc-92	49	2	the	the	DET
dpc-92	49	3	second	second	ADJ
dpc-92	49	4	phase	phase	NOUN
dpc-92	49	5	,	,	PUNCT
dpc-92	49	6	in	in	ADP
dpc-92	49	7	cases	case	NOUN
dpc-92	49	8	of	of	ADP
dpc-92	49	9	relapse	relapse	NOUN
dpc-92	49	10	or	or	CCONJ
dpc-92	49	11	flare	flare	NOUN
dpc-92	49	12	of	of	ADP
dpc-92	49	13	disease	disease	NOUN
dpc-92	49	14	,	,	PUNCT
dpc-92	49	15	patients	patient	NOUN
dpc-92	49	16	of	of	ADP
dpc-92	49	17	either	either	DET
dpc-92	49	18	group	group	NOUN
dpc-92	49	19	were	be	AUX
dpc-92	49	20	allowed	allow	VERB
dpc-92	49	21	to	to	PART
dpc-92	49	22	use	use	VERB
dpc-92	49	23	topical	topical	ADJ
dpc-92	49	24	treatment	treatment	NOUN
dpc-92	49	25	(	(	PUNCT
dpc-92	49	26	1	1	NUM
dpc-92	49	27	%	%	NOUN
dpc-92	49	28	hydrocortisone	hydrocortisone	NOUN
dpc-92	49	29	ointment	ointment	NOUN
dpc-92	49	30	once	once	ADV
dpc-92	49	31	daily	daily	ADV
dpc-92	49	32	and	and	CCONJ
dpc-92	49	33	2	2	NUM
dpc-92	49	34	%	%	NOUN
dpc-92	49	35	ketoconazole	ketoconazole	NOUN
dpc-92	49	36	cream	cream	NOUN
dpc-92	49	37	twice	twice	ADV
dpc-92	49	38	daily	daily	ADV
dpc-92	49	39	)	)	PUNCT
dpc-92	49	40	for	for	ADP
dpc-92	49	41	a	a	DET
dpc-92	49	42	maximum	maximum	NOUN
dpc-92	49	43	of	of	ADP
dpc-92	49	44	three	three	NUM
dpc-92	49	45	days	day	NOUN
dpc-92	49	46	as	as	ADP
dpc-92	49	47	a	a	DET
dpc-92	49	48	rescue	rescue	NOUN
dpc-92	49	49	regimen	regiman	NOUN
dpc-92	49	50	after	after	ADP
dpc-92	49	51	informing	inform	VERB
dpc-92	49	52	the	the	DET
dpc-92	49	53	study	study	NOUN
dpc-92	49	54	investigator	investigator	NOUN
dpc-92	49	55	.	.	PUNCT
dpc-92	50	1	statistical	statistical	ADJ
dpc-92	50	2	analysis	analysis	NOUN
dpc-92	50	3	was	be	AUX
dpc-92	50	4	performed	perform	VERB
dpc-92	50	5	using	use	VERB
dpc-92	50	6	ibm	ibm	PROPN
dpc-92	50	7	spss	spss	PROPN
dpc-92	50	8	software	software	NOUN
dpc-92	50	9	.	.	PUNCT
dpc-92	51	1	the	the	DET
dpc-92	51	2	difference	difference	NOUN
dpc-92	51	3	in	in	ADP
dpc-92	51	4	sdasi	sdasi	NOUN
dpc-92	51	5	,	,	PUNCT
dpc-92	51	6	symptom	symptom	NOUN
dpc-92	51	7	severity	severity	NOUN
dpc-92	51	8	and	and	CCONJ
dpc-92	51	9	dlqi	dlqi	ADJ
dpc-92	51	10	scores	score	NOUN
dpc-92	51	11	before	before	ADV
dpc-92	51	12	and	and	CCONJ
dpc-92	51	13	after	after	ADP
dpc-92	51	14	therapy	therapy	NOUN
dpc-92	51	15	was	be	AUX
dpc-92	51	16	compared	compare	VERB
dpc-92	51	17	by	by	ADP
dpc-92	51	18	using	use	VERB
dpc-92	51	19	paired	pair	VERB
dpc-92	51	20	t	t	NOUN
dpc-92	51	21	-	-	PUNCT
dpc-92	51	22	test	test	NOUN
dpc-92	51	23	.	.	PUNCT
dpc-92	52	1	comparisons	comparison	NOUN
dpc-92	52	2	of	of	ADP
dpc-92	52	3	mean	mean	ADJ
dpc-92	52	4	age	age	NOUN
dpc-92	52	5	,	,	PUNCT
dpc-92	52	6	disease	disease	NOUN
dpc-92	52	7	duration	duration	NOUN
dpc-92	52	8	,	,	PUNCT
dpc-92	52	9	number	number	NOUN
dpc-92	52	10	of	of	ADP
dpc-92	52	11	relapses	relapse	NOUN
dpc-92	52	12	and	and	CCONJ
dpc-92	52	13	bmi	bmi	NOUN
dpc-92	52	14	between	between	ADP
dpc-92	52	15	itraconazole	itraconazole	NOUN
dpc-92	52	16	and	and	CCONJ
dpc-92	52	17	placebo	placebo	NOUN
dpc-92	52	18	groups	group	NOUN
dpc-92	52	19	and	and	CCONJ
dpc-92	52	20	placebo	placebo	NOUN
dpc-92	52	21	were	be	AUX
dpc-92	52	22	in	in	ADP
dpc-92	52	23	capsule	capsule	NOUN
dpc-92	52	24	form	form	NOUN
dpc-92	52	25	and	and	CCONJ
dpc-92	52	26	identical	identical	ADJ
dpc-92	52	27	in	in	ADP
dpc-92	52	28	appearance	appearance	NOUN
dpc-92	52	29	and	and	CCONJ
dpc-92	52	30	were	be	AUX
dpc-92	52	31	delivered	deliver	VERB
dpc-92	52	32	to	to	ADP
dpc-92	52	33	patients	patient	NOUN
dpc-92	52	34	by	by	ADP
dpc-92	52	35	a	a	DET
dpc-92	52	36	third	third	ADJ
dpc-92	52	37	person	person	NOUN
dpc-92	52	38	recruited	recruit	VERB
dpc-92	52	39	for	for	ADP
dpc-92	52	40	this	this	DET
dpc-92	52	41	purpose	purpose	NOUN
dpc-92	52	42	.	.	PUNCT
dpc-92	53	1	the	the	DET
dpc-92	53	2	study	study	NOUN
dpc-92	53	3	investigator	investigator	NOUN
dpc-92	53	4	and	and	CCONJ
dpc-92	53	5	patients	patient	NOUN
dpc-92	53	6	were	be	AUX
dpc-92	53	7	blind	blind	ADJ
dpc-92	53	8	to	to	ADP
dpc-92	53	9	intervention	intervention	NOUN
dpc-92	53	10	,	,	PUNCT
dpc-92	53	11	and	and	CCONJ
dpc-92	53	12	that	that	PRON
dpc-92	53	13	was	be	AUX
dpc-92	53	14	maintained	maintain	VERB
dpc-92	53	15	until	until	SCONJ
dpc-92	53	16	patients	patient	NOUN
dpc-92	53	17	completed	complete	VERB
dpc-92	53	18	their	their	PRON
dpc-92	53	19	last	last	ADJ
dpc-92	53	20	follow	follow	NOUN
dpc-92	53	21	up	up	ADP
dpc-92	53	22	visit	visit	NOUN
dpc-92	53	23	.	.	PUNCT
dpc-92	54	1	the	the	DET
dpc-92	54	2	qol	qol	PROPN
dpc-92	54	3	was	be	AUX
dpc-92	54	4	assessed	assess	VERB
dpc-92	54	5	at	at	ADP
dpc-92	54	6	the	the	DET
dpc-92	54	7	start	start	NOUN
dpc-92	54	8	and	and	CCONJ
dpc-92	54	9	end	end	NOUN
dpc-92	54	10	of	of	ADP
dpc-92	54	11	the	the	DET
dpc-92	54	12	study	study	NOUN
dpc-92	54	13	by	by	ADP
dpc-92	54	14	a	a	DET
dpc-92	54	15	standard	standard	ADJ
dpc-92	54	16	dermatological	dermatological	ADJ
dpc-92	54	17	life	life	NOUN
dpc-92	54	18	quality	quality	NOUN
dpc-92	54	19	index	index	NOUN
dpc-92	54	20	(	(	PUNCT
dpc-92	54	21	dlqi	dlqi	ADJ
dpc-92	54	22	)	)	PUNCT
dpc-92	54	23	questionnaire	questionnaire	NOUN
dpc-92	54	24	(	(	PUNCT
dpc-92	54	25	persian	persian	ADJ
dpc-92	54	26	version	version	NOUN
dpc-92	54	27	)	)	PUNCT
dpc-92	54	28	filled	fill	VERB
dpc-92	54	29	by	by	ADP
dpc-92	54	30	patients	patient	NOUN
dpc-92	54	31	,	,	PUNCT
dpc-92	54	32	which	which	PRON
dpc-92	54	33	consisted	consist	VERB
dpc-92	54	34	of	of	ADP
dpc-92	54	35	10	10	NUM
dpc-92	54	36	questions	question	NOUN
dpc-92	54	37	each	each	PRON
dpc-92	54	38	referring	refer	VERB
dpc-92	54	39	to	to	ADP
dpc-92	54	40	the	the	DET
dpc-92	54	41	previous	previous	ADJ
dpc-92	54	42	week	week	NOUN
dpc-92	54	43	.	.	PUNCT
dpc-92	55	1	each	each	DET
dpc-92	55	2	question	question	NOUN
dpc-92	55	3	was	be	AUX
dpc-92	55	4	scored	score	VERB
dpc-92	55	5	from	from	ADP
dpc-92	55	6	3	3	NUM
dpc-92	55	7	(	(	PUNCT
dpc-92	55	8	very	very	ADV
dpc-92	55	9	much	much	ADJ
dpc-92	55	10	)	)	PUNCT
dpc-92	55	11	to	to	ADP
dpc-92	55	12	0	0	NUM
dpc-92	55	13	(	(	PUNCT
dpc-92	55	14	not	not	PART
dpc-92	55	15	relevant	relevant	ADJ
dpc-92	55	16	or	or	CCONJ
dpc-92	55	17	not	not	PART
dpc-92	55	18	at	at	ADV
dpc-92	55	19	all	all	ADV
dpc-92	55	20	)	)	PUNCT
dpc-92	55	21	.	.	PUNCT
dpc-92	56	1	the	the	DET
dpc-92	56	2	maximum	maximum	ADJ
dpc-92	56	3	possible	possible	ADJ
dpc-92	56	4	score	score	NOUN
dpc-92	56	5	was	be	AUX
dpc-92	56	6	30	30	NUM
dpc-92	56	7	.	.	PUNCT
dpc-92	57	1	a	a	DET
dpc-92	57	2	questionnaire	questionnaire	NOUN
dpc-92	57	3	including	include	VERB
dpc-92	57	4	the	the	DET
dpc-92	57	5	patient	patient	NOUN
dpc-92	57	6	’s	’s	PART
dpc-92	57	7	basic	basic	ADJ
dpc-92	57	8	profile	profile	NOUN
dpc-92	57	9	was	be	AUX
dpc-92	57	10	filled	fill	VERB
dpc-92	57	11	in	in	ADP
dpc-92	57	12	the	the	DET
dpc-92	57	13	first	first	ADJ
dpc-92	57	14	visit	visit	NOUN
dpc-92	57	15	for	for	ADP
dpc-92	57	16	assessing	assess	VERB
dpc-92	57	17	other	other	ADJ
dpc-92	57	18	secondary	secondary	ADJ
dpc-92	57	19	outcomes	outcome	NOUN
dpc-92	57	20	like	like	ADP
dpc-92	57	21	effect	effect	NOUN
dpc-92	57	22	of	of	ADP
dpc-92	57	23	age	age	NOUN
dpc-92	57	24	,	,	PUNCT
dpc-92	57	25	sex	sex	NOUN
dpc-92	57	26	,	,	PUNCT
dpc-92	57	27	education	education	NOUN
dpc-92	57	28	level	level	NOUN
dpc-92	57	29	,	,	PUNCT
dpc-92	57	30	disease	disease	NOUN
dpc-92	57	31	duration	duration	NOUN
dpc-92	57	32	,	,	PUNCT
dpc-92	57	33	number	number	NOUN
dpc-92	57	34	of	of	ADP
dpc-92	57	35	relapses	relapse	NOUN
dpc-92	57	36	and	and	CCONJ
dpc-92	57	37	body	body	NOUN
dpc-92	57	38	mass	mass	NOUN
dpc-92	57	39	index	index	NOUN
dpc-92	57	40	(	(	PUNCT
dpc-92	57	41	bmi	bmi	PROPN
dpc-92	57	42	)	)	PUNCT
dpc-92	57	43	on	on	ADP
dpc-92	57	44	qol	qol	PROPN
dpc-92	57	45	.	.	PUNCT
dpc-92	58	1	sdasi	sdasi	PROPN
dpc-92	58	2	was	be	AUX
dpc-92	58	3	used	use	VERB
dpc-92	58	4	to	to	PART
dpc-92	58	5	determine	determine	VERB
dpc-92	58	6	the	the	DET
dpc-92	58	7	disease	disease	NOUN
dpc-92	58	8	severity	severity	NOUN
dpc-92	58	9	.	.	PUNCT
dpc-92	59	1	this	this	DET
dpc-92	59	2	scoring	scoring	NOUN
dpc-92	59	3	system	system	NOUN
dpc-92	59	4	was	be	AUX
dpc-92	59	5	modified	modify	VERB
dpc-92	59	6	from	from	ADP
dpc-92	59	7	psoriasis	psoriasis	NOUN
dpc-92	59	8	area	area	NOUN
dpc-92	59	9	severity	severity	NOUN
dpc-92	59	10	index	index	NOUN
dpc-92	59	11	(	(	PUNCT
dpc-92	59	12	pasi	pasi	NOUN
dpc-92	59	13	)	)	PUNCT
dpc-92	59	14	and	and	CCONJ
dpc-92	59	15	the	the	DET
dpc-92	59	16	comert	comert	NOUN
dpc-92	59	17	et	et	PROPN
dpc-92	59	18	al	al	PROPN
dpc-92	59	19	study	study	PROPN
dpc-92	59	20	[	[	X
dpc-92	59	21	12	12	NUM
dpc-92	59	22	]	]	PUNCT
dpc-92	59	23	that	that	PRON
dpc-92	59	24	had	have	AUX
dpc-92	59	25	already	already	ADV
dpc-92	59	26	been	be	AUX
dpc-92	59	27	used	use	VERB
dpc-92	59	28	in	in	ADP
dpc-92	59	29	a	a	DET
dpc-92	59	30	previous	previous	ADJ
dpc-92	59	31	study	study	NOUN
dpc-92	59	32	by	by	ADP
dpc-92	59	33	ghodsi	ghodsi	PROPN
dpc-92	59	34	et	et	PROPN
dpc-92	59	35	al	al	PROPN
dpc-92	60	1	[	[	X
dpc-92	60	2	13	13	NUM
dpc-92	60	3	]	]	PUNCT
dpc-92	60	4	.	.	PUNCT
dpc-92	61	1	the	the	DET
dpc-92	61	2	treatment	treatment	NOUN
dpc-92	61	3	was	be	AUX
dpc-92	61	4	administered	administer	VERB
dpc-92	61	5	in	in	ADP
dpc-92	61	6	two	two	NUM
dpc-92	61	7	different	different	ADJ
dpc-92	61	8	phases	phase	NOUN
dpc-92	61	9	.	.	PUNCT
dpc-92	62	1	in	in	ADP
dpc-92	62	2	the	the	DET
dpc-92	62	3	first	first	ADJ
dpc-92	62	4	phase	phase	NOUN
dpc-92	62	5	(	(	PUNCT
dpc-92	62	6	initial	initial	ADJ
dpc-92	62	7	treatment	treatment	NOUN
dpc-92	62	8	)	)	PUNCT
dpc-92	62	9	,	,	PUNCT
dpc-92	62	10	topical	topical	ADJ
dpc-92	62	11	1	1	NUM
dpc-92	62	12	%	%	NOUN
dpc-92	62	13	hydrocortitable	hydrocortitable	ADJ
dpc-92	62	14	1	1	NUM
dpc-92	62	15	.	.	PUNCT
dpc-92	62	16	main	main	ADJ
dpc-92	62	17	characteristics	characteristic	NOUN
dpc-92	62	18	of	of	ADP
dpc-92	62	19	patients	patient	NOUN
dpc-92	62	20	at	at	ADP
dpc-92	62	21	baseline	baseline	NOUN
dpc-92	62	22	and	and	CCONJ
dpc-92	62	23	at	at	ADP
dpc-92	62	24	the	the	DET
dpc-92	62	25	end	end	NOUN
dpc-92	62	26	of	of	ADP
dpc-92	62	27	study	study	NOUN
dpc-92	62	28	[	[	X
dpc-92	62	29	copyright	copyright	NOUN
dpc-92	62	30	:	:	PUNCT
dpc-92	62	31	©	©	PROPN
dpc-92	62	32	2016	2016	NUM
dpc-92	62	33	abbas	abbas	PROPN
dpc-92	62	34	et	et	PROPN
dpc-92	62	35	al	al	PROPN
dpc-92	62	36	.	.	PROPN
dpc-92	62	37	]	]	PUNCT
dpc-92	63	1	itraconazole	itraconazole	PROPN
dpc-92	63	2	placebo	placebo	NOUN
dpc-92	63	3	p	p	NOUN
dpc-92	63	4	value	value	NOUN
dpc-92	63	5	patients	patient	NOUN
dpc-92	63	6	enrolled	enrol	VERB
dpc-92	63	7	sex	sex	NOUN
dpc-92	63	8	,	,	PUNCT
dpc-92	63	9	n	n	CCONJ
dpc-92	63	10	(	(	PUNCT
dpc-92	63	11	%	%	INTJ
dpc-92	63	12	)	)	PUNCT
dpc-92	63	13	male	male	ADJ
dpc-92	63	14	female	female	ADJ
dpc-92	63	15	education	education	NOUN
dpc-92	63	16	level	level	NOUN
dpc-92	63	17	,	,	PUNCT
dpc-92	63	18	n	n	CCONJ
dpc-92	63	19	(	(	PUNCT
dpc-92	63	20	%	%	INTJ
dpc-92	63	21	)	)	PUNCT
dpc-92	63	22	intermediate	intermediate	ADJ
dpc-92	63	23	bachelor	bachelor	NOUN
dpc-92	63	24	master	master	NOUN
dpc-92	63	25	/	/	SYM
dpc-92	63	26	phd	phd	PROPN
dpc-92	63	27	n=35	n=35	PROPN
dpc-92	63	28	23	23	NUM
dpc-92	63	29	(	(	PUNCT
dpc-92	63	30	65.7	65.7	NUM
dpc-92	63	31	%	%	NOUN
dpc-92	63	32	)	)	PUNCT
dpc-92	63	33	12	12	NUM
dpc-92	63	34	(	(	PUNCT
dpc-92	63	35	34.3	34.3	NUM
dpc-92	63	36	%	%	NOUN
dpc-92	63	37	)	)	PUNCT
dpc-92	63	38	19	19	NUM
dpc-92	63	39	(	(	PUNCT
dpc-92	63	40	54.3	54.3	NUM
dpc-92	63	41	%	%	NOUN
dpc-92	63	42	)	)	PUNCT
dpc-92	63	43	14	14	NUM
dpc-92	63	44	(	(	PUNCT
dpc-92	63	45	40.0	40.0	NUM
dpc-92	63	46	%	%	NOUN
dpc-92	63	47	)	)	PUNCT
dpc-92	63	48	2	2	NUM
dpc-92	63	49	(	(	PUNCT
dpc-92	63	50	5.71	5.71	NUM
dpc-92	63	51	%	%	NOUN
dpc-92	63	52	)	)	PUNCT
dpc-92	64	1	n=33	n=33	NOUN
dpc-92	64	2	24	24	NUM
dpc-92	64	3	(	(	PUNCT
dpc-92	64	4	72.7	72.7	NUM
dpc-92	64	5	%	%	NOUN
dpc-92	64	6	)	)	PUNCT
dpc-92	64	7	9	9	NUM
dpc-92	64	8	(	(	PUNCT
dpc-92	64	9	27.3	27.3	NUM
dpc-92	64	10	%	%	NOUN
dpc-92	64	11	)	)	PUNCT
dpc-92	64	12	20	20	NUM
dpc-92	64	13	(	(	PUNCT
dpc-92	64	14	60.6	60.6	NUM
dpc-92	64	15	%	%	NOUN
dpc-92	64	16	)	)	PUNCT
dpc-92	64	17	13	13	NUM
dpc-92	64	18	(	(	PUNCT
dpc-92	64	19	39.4	39.4	NUM
dpc-92	64	20	%	%	NOUN
dpc-92	64	21	)	)	PUNCT
dpc-92	64	22	0	0	NUM
dpc-92	64	23	0.532	0.532	NUM
dpc-92	64	24	0.652	0.652	NUM
dpc-92	64	25	age	age	NOUN
dpc-92	64	26	(	(	PUNCT
dpc-92	64	27	years	year	NOUN
dpc-92	64	28	)	)	PUNCT
dpc-92	64	29	,	,	PUNCT
dpc-92	64	30	mean	mean	VERB
dpc-92	64	31	±sd	±sd	PRON
dpc-92	64	32	duration	duration	NOUN
dpc-92	64	33	of	of	ADP
dpc-92	64	34	disease	disease	NOUN
dpc-92	64	35	(	(	PUNCT
dpc-92	64	36	years	year	NOUN
dpc-92	64	37	)	)	PUNCT
dpc-92	64	38	,	,	PUNCT
dpc-92	64	39	mean	mean	VERB
dpc-92	64	40	±sd	±sd	NOUN
dpc-92	64	41	number	number	NOUN
dpc-92	64	42	of	of	ADP
dpc-92	64	43	relapses	relapse	NOUN
dpc-92	64	44	before	before	ADP
dpc-92	64	45	treatment	treatment	NOUN
dpc-92	64	46	,	,	PUNCT
dpc-92	64	47	mean	mean	VERB
dpc-92	64	48	±sd	±sd	PRON
dpc-92	64	49	bmi(kg	bmi(kg	NOUN
dpc-92	64	50	/	/	SYM
dpc-92	64	51	m2	m2	PROPN
dpc-92	64	52	)	)	PUNCT
dpc-92	64	53	,	,	PUNCT
dpc-92	64	54	mean	mean	VERB
dpc-92	64	55	±sd	±sd	DET
dpc-92	64	56	quality	quality	NOUN
dpc-92	64	57	of	of	ADP
dpc-92	64	58	life	life	NOUN
dpc-92	64	59	(	(	PUNCT
dpc-92	64	60	dlqi	dlqi	ADJ
dpc-92	64	61	)	)	PUNCT
dpc-92	64	62	,	,	PUNCT
dpc-92	64	63	mean	mean	VERB
dpc-92	64	64	±sd	±sd	PRON
dpc-92	65	1	28.17	28.17	NUM
dpc-92	65	2	±7.32	±7.32	PROPN
dpc-92	65	3	4.19±3.93	4.19±3.93	PROPN
dpc-92	65	4	5.17±5.12	5.17±5.12	PROPN
dpc-92	65	5	23.03±3.67	23.03±3.67	NUM
dpc-92	65	6	6.66±4.64	6.66±4.64	NUM
dpc-92	65	7	26.45±8.09	26.45±8.09	NUM
dpc-92	65	8	4.76±4.56	4.76±4.56	NUM
dpc-92	65	9	6.45±7.83	6.45±7.83	PROPN
dpc-92	65	10	23.38±3.11	23.38±3.11	NUM
dpc-92	65	11	4.88±3.78	4.88±3.78	NOUN
dpc-92	65	12	0.362	0.362	NUM
dpc-92	65	13	0.581	0.581	NUM
dpc-92	65	14	0.424	0.424	NUM
dpc-92	65	15	0.670	0.670	NUM
dpc-92	65	16	0.089	0.089	NUM
dpc-92	65	17	patients	patient	NOUN
dpc-92	65	18	who	who	PRON
dpc-92	65	19	completed	complete	VERB
dpc-92	65	20	the	the	DET
dpc-92	65	21	study	study	NOUN
dpc-92	65	22	quality	quality	NOUN
dpc-92	65	23	of	of	ADP
dpc-92	65	24	life	life	NOUN
dpc-92	65	25	(	(	PUNCT
dpc-92	65	26	dlqi	dlqi	ADJ
dpc-92	65	27	)	)	PUNCT
dpc-92	65	28	,	,	PUNCT
dpc-92	65	29	mean	mean	VERB
dpc-92	65	30	±sd	±sd	NOUN
dpc-92	65	31	before	before	ADP
dpc-92	65	32	aftera	aftera	ADJ
dpc-92	65	33	severity	severity	NOUN
dpc-92	65	34	of	of	ADP
dpc-92	65	35	sd	sd	ADP
dpc-92	65	36	(	(	PUNCT
dpc-92	65	37	sadsi	sadsi	PROPN
dpc-92	65	38	)	)	PUNCT
dpc-92	65	39	,	,	PUNCT
dpc-92	65	40	mean	mean	VERB
dpc-92	65	41	±sd	±sd	PRON
dpc-92	65	42	baseline	baseline	NOUN
dpc-92	65	43	at	at	ADP
dpc-92	65	44	the	the	DET
dpc-92	65	45	end	end	NOUN
dpc-92	65	46	of	of	ADP
dpc-92	65	47	studya	studya	NOUN
dpc-92	65	48	itching	itching	NOUN
dpc-92	65	49	,	,	PUNCT
dpc-92	65	50	mean	mean	VERB
dpc-92	65	51	±sd	±sd	PRON
dpc-92	65	52	baseline	baseline	NOUN
dpc-92	65	53	at	at	ADP
dpc-92	65	54	the	the	DET
dpc-92	65	55	end	end	NOUN
dpc-92	65	56	of	of	ADP
dpc-92	65	57	studya	studya	NOUN
dpc-92	65	58	burning	burn	VERB
dpc-92	65	59	sensation	sensation	NOUN
dpc-92	65	60	,	,	PUNCT
dpc-92	65	61	mean	mean	VERB
dpc-92	65	62	±sd	±sd	PRON
dpc-92	65	63	baseline	baseline	NOUN
dpc-92	65	64	at	at	ADP
dpc-92	65	65	the	the	DET
dpc-92	65	66	end	end	NOUN
dpc-92	65	67	of	of	ADP
dpc-92	65	68	studya	studya	ADJ
dpc-92	65	69	side	side	NOUN
dpc-92	65	70	effectsb	effectsb	NOUN
dpc-92	65	71	,	,	PUNCT
dpc-92	65	72	n	n	CCONJ
dpc-92	65	73	(	(	PUNCT
dpc-92	65	74	%	%	INTJ
dpc-92	65	75	)	)	PUNCT
dpc-92	65	76	n=29	n=29	ADJ
dpc-92	65	77	6.72±4.67	6.72±4.67	NUM
dpc-92	66	1	1.79±1.63	1.79±1.63	NUM
dpc-92	66	2	9.78±4.41	9.78±4.41	NUM
dpc-92	66	3	1.82±1.66	1.82±1.66	NUM
dpc-92	67	1	2.00±0.84	2.00±0.84	NOUN
dpc-92	67	2	0.52±0.63	0.52±0.63	ADJ
dpc-92	67	3	1.17±1.07	1.17±1.07	NUM
dpc-92	67	4	0.17±0.46	0.17±0.46	NOUN
dpc-92	67	5	3	3	NUM
dpc-92	67	6	(	(	PUNCT
dpc-92	67	7	10.3	10.3	NUM
dpc-92	67	8	%	%	NOUN
dpc-92	67	9	)	)	PUNCT
dpc-92	67	10	n=28	n=28	PUNCT
dpc-92	68	1	5.04±3.87	5.04±3.87	NUM
dpc-92	68	2	3.57±3.27	3.57±3.27	NUM
dpc-92	68	3	10.47±3.71	10.47±3.71	NUM
dpc-92	68	4	5.47±2.19	5.47±2.19	NUM
dpc-92	68	5	1.68±0.67	1.68±0.67	NUM
dpc-92	68	6	1.07±0.53	1.07±0.53	NUM
dpc-92	68	7	0.71±0.65	0.71±0.65	NOUN
dpc-92	68	8	0.43±0.50	0.43±0.50	PROPN
dpc-92	68	9	5	5	NUM
dpc-92	68	10	(	(	PUNCT
dpc-92	68	11	17.9	17.9	NUM
dpc-92	68	12	%	%	NOUN
dpc-92	68	13	)	)	PUNCT
dpc-92	68	14	0.001	0.001	NUM
dpc-92	68	15	0.023	0.023	NUM
dpc-92	68	16	0.002	0.002	NUM
dpc-92	68	17	0.003	0.003	NUM
dpc-92	68	18	0.470	0.470	NUM
dpc-92	68	19	sdasi	sdasi	NOUN
dpc-92	68	20	seborrheic	seborrheic	PROPN
dpc-92	68	21	dermatitis	dermatitis	PROPN
dpc-92	68	22	area	area	PROPN
dpc-92	68	23	severity	severity	PROPN
dpc-92	68	24	index	index	NOUN
dpc-92	68	25	,	,	PUNCT
dpc-92	68	26	dlqi	dlqi	VERB
dpc-92	68	27	dermatology	dermatology	NOUN
dpc-92	68	28	life	life	NOUN
dpc-92	68	29	quality	quality	PROPN
dpc-92	68	30	index	index	NOUN
dpc-92	68	31	,	,	PUNCT
dpc-92	68	32	bmi	bmi	PROPN
dpc-92	68	33	body	body	PROPN
dpc-92	68	34	mass	mass	PROPN
dpc-92	68	35	index	index	NOUN
dpc-92	68	36	,	,	PUNCT
dpc-92	68	37	sd	sd	ADP
dpc-92	68	38	seborrheic	seborrheic	PROPN
dpc-92	68	39	dermatitis	dermatitis	NOUN
dpc-92	68	40	a	a	PRON
dpc-92	68	41	at	at	ADP
dpc-92	68	42	the	the	DET
dpc-92	68	43	end	end	NOUN
dpc-92	68	44	of	of	ADP
dpc-92	68	45	study	study	NOUN
dpc-92	68	46	=	=	PROPN
dpc-92	68	47	at	at	ADP
dpc-92	68	48	the	the	DET
dpc-92	68	49	end	end	NOUN
dpc-92	68	50	of	of	ADP
dpc-92	68	51	16	16	NUM
dpc-92	68	52	weeks	week	NOUN
dpc-92	68	53	,	,	PUNCT
dpc-92	68	54	b	b	X
dpc-92	68	55	nausea	nausea	NOUN
dpc-92	68	56	,	,	PUNCT
dpc-92	68	57	abdominal	abdominal	ADJ
dpc-92	68	58	pain	pain	NOUN
dpc-92	68	59	,	,	PUNCT
dpc-92	68	60	diarrhea	diarrhea	NOUN
dpc-92	68	61	14	14	NUM
dpc-92	68	62	research	research	NOUN
dpc-92	68	63	|	|	ADV
dpc-92	68	64	dermatol	dermatol	NOUN
dpc-92	68	65	pract	pract	NOUN
dpc-92	68	66	concept	concept	NOUN
dpc-92	68	67	2016;6(3):4	2016;6(3):4	NOUN
dpc-92	68	68	significantly	significantly	ADV
dpc-92	68	69	in	in	ADP
dpc-92	68	70	both	both	DET
dpc-92	68	71	groups	group	NOUN
dpc-92	68	72	(	(	PUNCT
dpc-92	68	73	table	table	NOUN
dpc-92	68	74	1	1	NUM
dpc-92	68	75	)	)	PUNCT
dpc-92	68	76	,	,	PUNCT
dpc-92	68	77	patients	patient	NOUN
dpc-92	68	78	taking	take	VERB
dpc-92	68	79	itraconazole	itraconazole	NOUN
dpc-92	68	80	had	have	VERB
dpc-92	68	81	greater	great	ADJ
dpc-92	68	82	reduction	reduction	NOUN
dpc-92	68	83	compared	compare	VERB
dpc-92	68	84	to	to	ADP
dpc-92	68	85	placebo	placebo	NOUN
dpc-92	68	86	(	(	PUNCT
dpc-92	68	87	p	p	NOUN
dpc-92	68	88	=	=	NOUN
dpc-92	68	89	0.001	0.001	NUM
dpc-92	68	90	)	)	PUNCT
dpc-92	68	91	(	(	PUNCT
dpc-92	68	92	figure	figure	NOUN
dpc-92	68	93	2	2	NUM
dpc-92	68	94	)	)	PUNCT
dpc-92	68	95	.	.	PUNCT
dpc-92	69	1	the	the	DET
dpc-92	69	2	most	most	ADV
dpc-92	69	3	compromised	compromise	VERB
dpc-92	69	4	elements	element	NOUN
dpc-92	69	5	of	of	ADP
dpc-92	69	6	qol	qol	PROPN
dpc-92	69	7	were	be	AUX
dpc-92	69	8	clinical	clinical	ADJ
dpc-92	69	9	symptoms	symptom	NOUN
dpc-92	69	10	,	,	PUNCT
dpc-92	69	11	feelings	feeling	NOUN
dpc-92	69	12	(	(	PUNCT
dpc-92	69	13	question	question	NOUN
dpc-92	69	14	1	1	NUM
dpc-92	69	15	,	,	PUNCT
dpc-92	69	16	2	2	NUM
dpc-92	69	17	of	of	ADP
dpc-92	69	18	dlqi	dlqi	PROPN
dpc-92	69	19	)	)	PUNCT
dpc-92	69	20	and	and	CCONJ
dpc-92	69	21	daily	daily	ADJ
dpc-92	69	22	activities	activity	NOUN
dpc-92	69	23	(	(	PUNCT
dpc-92	69	24	question	question	NOUN
dpc-92	69	25	3	3	NUM
dpc-92	69	26	,	,	PUNCT
dpc-92	69	27	4	4	NUM
dpc-92	69	28	)	)	PUNCT
dpc-92	69	29	(	(	PUNCT
dpc-92	69	30	figure	figure	NOUN
dpc-92	69	31	3	3	NUM
dpc-92	69	32	)	)	PUNCT
dpc-92	69	33	.	.	PUNCT
dpc-92	70	1	qol	qol	PROPN
dpc-92	70	2	was	be	AUX
dpc-92	70	3	not	not	PART
dpc-92	70	4	affected	affect	VERB
dpc-92	70	5	by	by	ADP
dpc-92	70	6	age	age	NOUN
dpc-92	70	7	,	,	PUNCT
dpc-92	70	8	sex	sex	NOUN
dpc-92	70	9	,	,	PUNCT
dpc-92	70	10	educational	educational	ADJ
dpc-92	70	11	level	level	NOUN
dpc-92	70	12	,	,	PUNCT
dpc-92	70	13	bmi	bmi	NOUN
dpc-92	70	14	,	,	PUNCT
dpc-92	70	15	disease	disease	NOUN
dpc-92	70	16	duration	duration	NOUN
dpc-92	70	17	and	and	CCONJ
dpc-92	70	18	number	number	NOUN
dpc-92	70	19	of	of	ADP
dpc-92	70	20	relapses	relapse	NOUN
dpc-92	70	21	(	(	PUNCT
dpc-92	70	22	p	p	X
dpc-92	70	23	>	>	X
dpc-92	70	24	0.05	0.05	NUM
dpc-92	70	25	)	)	PUNCT
dpc-92	70	26	but	but	CCONJ
dpc-92	70	27	was	be	AUX
dpc-92	70	28	impaired	impair	VERB
dpc-92	70	29	significantly	significantly	ADV
dpc-92	70	30	with	with	ADP
dpc-92	70	31	high	high	ADJ
dpc-92	70	32	disease	disease	NOUN
dpc-92	70	33	severity	severity	NOUN
dpc-92	70	34	(	(	PUNCT
dpc-92	70	35	sdasi	sdasi	NOUN
dpc-92	70	36	)	)	PUNCT
dpc-92	70	37	(	(	PUNCT
dpc-92	70	38	p	p	NOUN
dpc-92	70	39	=	=	NOUN
dpc-92	70	40	0.002	0.002	NUM
dpc-92	70	41	)	)	PUNCT
dpc-92	70	42	and	and	CCONJ
dpc-92	70	43	presence	presence	NOUN
dpc-92	70	44	of	of	ADP
dpc-92	70	45	symptoms	symptom	NOUN
dpc-92	70	46	(	(	PUNCT
dpc-92	70	47	itching	itching	NOUN
dpc-92	70	48	and	and	CCONJ
dpc-92	70	49	burning	burn	VERB
dpc-92	70	50	sensation	sensation	NOUN
dpc-92	70	51	)	)	PUNCT
dpc-92	71	1	(	(	PUNCT
dpc-92	71	2	p	p	NOUN
dpc-92	71	3	=	=	PROPN
dpc-92	71	4	0.001	0.001	NUM
dpc-92	71	5	each	each	PRON
dpc-92	71	6	)	)	PUNCT
dpc-92	71	7	.	.	PUNCT
dpc-92	72	1	furthermore	furthermore	ADV
dpc-92	72	2	,	,	PUNCT
dpc-92	72	3	dlqi	dlqi	PROPN
dpc-92	72	4	was	be	AUX
dpc-92	72	5	not	not	PART
dpc-92	72	6	significantly	significantly	ADV
dpc-92	72	7	different	different	ADJ
dpc-92	72	8	between	between	ADP
dpc-92	72	9	the	the	DET
dpc-92	72	10	two	two	NUM
dpc-92	72	11	groups	group	NOUN
dpc-92	72	12	of	of	ADP
dpc-92	72	13	itraconazole	itraconazole	NOUN
dpc-92	72	14	and	and	CCONJ
dpc-92	72	15	placebo	placebo	NOUN
dpc-92	72	16	(	(	PUNCT
dpc-92	72	17	p	p	NOUN
dpc-92	72	18	=	=	NOUN
dpc-92	72	19	0.089	0.089	NUM
dpc-92	72	20	)	)	PUNCT
dpc-92	72	21	.	.	PUNCT
dpc-92	73	1	the	the	DET
dpc-92	73	2	most	most	ADV
dpc-92	73	3	common	common	ADJ
dpc-92	73	4	site	site	NOUN
dpc-92	73	5	involved	involve	VERB
dpc-92	73	6	in	in	ADP
dpc-92	73	7	our	our	PRON
dpc-92	73	8	study	study	NOUN
dpc-92	73	9	was	be	AUX
dpc-92	73	10	the	the	DET
dpc-92	73	11	scalp	scalp	NOUN
dpc-92	73	12	,	,	PUNCT
dpc-92	73	13	but	but	CCONJ
dpc-92	73	14	the	the	DET
dpc-92	73	15	location	location	NOUN
dpc-92	73	16	with	with	ADP
dpc-92	73	17	significant	significant	ADJ
dpc-92	73	18	effect	effect	NOUN
dpc-92	73	19	on	on	ADP
dpc-92	73	20	quality	quality	NOUN
dpc-92	73	21	of	of	ADP
dpc-92	73	22	life	life	NOUN
dpc-92	73	23	was	be	AUX
dpc-92	73	24	the	the	DET
dpc-92	73	25	face	face	NOUN
dpc-92	73	26	(	(	PUNCT
dpc-92	73	27	including	include	VERB
dpc-92	73	28	forehead	forehead	NOUN
dpc-92	73	29	,	,	PUNCT
dpc-92	73	30	eyebrows	eyebrow	NOUN
dpc-92	73	31	,	,	PUNCT
dpc-92	73	32	nasolabial	nasolabial	ADJ
dpc-92	73	33	folds	fold	NOUN
dpc-92	73	34	and	and	CCONJ
dpc-92	73	35	cheeks	cheek	NOUN
dpc-92	73	36	collectively	collectively	ADV
dpc-92	73	37	compared	compare	VERB
dpc-92	73	38	with	with	ADP
dpc-92	73	39	scalp	scalp	NOUN
dpc-92	73	40	and	and	CCONJ
dpc-92	73	41	trunk	trunk	NOUN
dpc-92	73	42	)	)	PUNCT
dpc-92	73	43	(	(	PUNCT
dpc-92	73	44	p	p	NOUN
dpc-92	73	45	=	=	NOUN
dpc-92	73	46	0.017	0.017	NUM
dpc-92	73	47	)	)	PUNCT
dpc-92	73	48	.	.	PUNCT
dpc-92	74	1	one	one	NUM
dpc-92	74	2	patient	patient	NOUN
dpc-92	74	3	in	in	ADP
dpc-92	74	4	the	the	DET
dpc-92	74	5	itraconazole	itraconazole	ADJ
dpc-92	74	6	group	group	NOUN
dpc-92	74	7	as	as	SCONJ
dpc-92	74	8	opposed	oppose	VERB
dpc-92	74	9	to	to	ADP
dpc-92	74	10	four	four	NUM
dpc-92	74	11	patients	patient	NOUN
dpc-92	74	12	in	in	ADP
dpc-92	74	13	the	the	DET
dpc-92	74	14	placebo	placebo	NOUN
dpc-92	74	15	group	group	NOUN
dpc-92	74	16	required	require	VERB
dpc-92	74	17	rescue	rescue	NOUN
dpc-92	74	18	medication	medication	NOUN
dpc-92	74	19	in	in	ADP
dpc-92	74	20	the	the	DET
dpc-92	74	21	second	second	ADJ
dpc-92	74	22	phase	phase	NOUN
dpc-92	74	23	of	of	ADP
dpc-92	74	24	the	the	DET
dpc-92	74	25	study	study	NOUN
dpc-92	74	26	.	.	PUNCT
dpc-92	75	1	side	side	NOUN
dpc-92	75	2	effects	effect	NOUN
dpc-92	75	3	like	like	ADP
dpc-92	75	4	nausea	nausea	NOUN
dpc-92	75	5	,	,	PUNCT
dpc-92	75	6	mild	mild	ADJ
dpc-92	75	7	abdominal	abdominal	ADJ
dpc-92	75	8	pain	pain	NOUN
dpc-92	75	9	and	and	CCONJ
dpc-92	75	10	diarrhea	diarrhea	NOUN
dpc-92	75	11	were	be	AUX
dpc-92	75	12	reported	report	VERB
dpc-92	75	13	by	by	ADP
dpc-92	75	14	only	only	ADV
dpc-92	75	15	three	three	NUM
dpc-92	75	16	patients	patient	NOUN
dpc-92	75	17	in	in	ADP
dpc-92	75	18	itraconazole	itraconazole	PROPN
dpc-92	75	19	group	group	PROPN
dpc-92	75	20	.	.	PUNCT
dpc-92	76	1	discussion	discussion	NOUN
dpc-92	76	2	in	in	ADP
dpc-92	76	3	our	our	PRON
dpc-92	76	4	study	study	NOUN
dpc-92	76	5	,	,	PUNCT
dpc-92	76	6	we	we	PRON
dpc-92	76	7	showed	show	VERB
dpc-92	76	8	that	that	SCONJ
dpc-92	76	9	quality	quality	NOUN
dpc-92	76	10	of	of	ADP
dpc-92	76	11	life	life	NOUN
dpc-92	76	12	is	be	AUX
dpc-92	76	13	significantly	significantly	ADV
dpc-92	76	14	improved	improve	VERB
dpc-92	76	15	by	by	ADP
dpc-92	76	16	systemic	systemic	ADJ
dpc-92	76	17	itraconazole	itraconazole	NOUN
dpc-92	76	18	in	in	ADP
dpc-92	76	19	moderate	moderate	ADJ
dpc-92	76	20	to	to	ADP
dpc-92	76	21	severe	severe	ADJ
dpc-92	76	22	sd	sd	ADP
dpc-92	76	23	patients	patient	NOUN
dpc-92	76	24	.	.	PUNCT
dpc-92	77	1	one	one	NUM
dpc-92	77	2	of	of	ADP
dpc-92	77	3	the	the	DET
dpc-92	77	4	important	important	ADJ
dpc-92	77	5	findings	finding	NOUN
dpc-92	77	6	of	of	ADP
dpc-92	77	7	our	our	PRON
dpc-92	77	8	study	study	NOUN
dpc-92	77	9	was	be	AUX
dpc-92	77	10	that	that	SCONJ
dpc-92	77	11	patients	patient	NOUN
dpc-92	77	12	in	in	ADP
dpc-92	77	13	the	the	DET
dpc-92	77	14	itraconazole	itraconazole	PROPN
dpc-92	77	15	group	group	NOUN
dpc-92	77	16	had	have	AUX
dpc-92	77	17	experienced	experience	VERB
dpc-92	77	18	a	a	DET
dpc-92	77	19	73.36	73.36	NUM
dpc-92	77	20	%	%	NOUN
dpc-92	77	21	reduction	reduction	NOUN
dpc-92	77	22	in	in	ADP
dpc-92	77	23	dlqi	dlqi	NOUN
dpc-92	77	24	after	after	ADP
dpc-92	77	25	four	four	NUM
dpc-92	77	26	months	month	NOUN
dpc-92	77	27	’	'	PUNCT
dpc-92	77	28	treatment	treatment	NOUN
dpc-92	77	29	,	,	PUNCT
dpc-92	77	30	compared	compare	VERB
dpc-92	77	31	with	with	ADP
dpc-92	77	32	29.16	29.16	NUM
dpc-92	77	33	%	%	NOUN
dpc-92	77	34	in	in	ADP
dpc-92	77	35	the	the	DET
dpc-92	77	36	placebo	placebo	NOUN
dpc-92	77	37	group	group	NOUN
dpc-92	77	38	,	,	PUNCT
dpc-92	77	39	and	and	CCONJ
dpc-92	77	40	this	this	DET
dpc-92	77	41	effect	effect	NOUN
dpc-92	77	42	of	of	ADP
dpc-92	77	43	itraconazole	itraconazole	NOUN
dpc-92	77	44	on	on	ADP
dpc-92	77	45	severe	severe	ADJ
dpc-92	77	46	sd	sd	NOUN
dpc-92	77	47	(	(	PUNCT
dpc-92	77	48	mean	mean	INTJ
dpc-92	77	49	dlqi	dlqi	VERB
dpc-92	77	50	before	before	ADP
dpc-92	77	51	6.72	6.72	NUM
dpc-92	77	52	and	and	CCONJ
dpc-92	77	53	after	after	ADP
dpc-92	77	54	1.79	1.79	NUM
dpc-92	77	55	)	)	PUNCT
dpc-92	77	56	is	be	AUX
dpc-92	77	57	comparable	comparable	ADJ
dpc-92	77	58	to	to	ADP
dpc-92	77	59	systemic	systemic	ADJ
dpc-92	77	60	isotretinoin	isotretinoin	NOUN
dpc-92	77	61	in	in	ADP
dpc-92	77	62	acne	acne	NOUN
dpc-92	77	63	patients	patient	NOUN
dpc-92	77	64	(	(	PUNCT
dpc-92	77	65	mean	mean	INTJ
dpc-92	77	66	dlqi	dlqi	VERB
dpc-92	77	67	before=6.7	before=6.7	ADV
dpc-92	77	68	,	,	PUNCT
dpc-92	77	69	after=2.8	after=2.8	NOUN
dpc-92	77	70	)	)	PUNCT
dpc-92	78	1	[	[	X
dpc-92	78	2	14	14	NUM
dpc-92	78	3	]	]	PUNCT
dpc-92	78	4	.	.	PUNCT
dpc-92	79	1	were	be	AUX
dpc-92	79	2	performed	perform	VERB
dpc-92	79	3	using	use	VERB
dpc-92	79	4	unpaired	unpaired	ADJ
dpc-92	79	5	t	t	NOUN
dpc-92	79	6	-	-	PUNCT
dpc-92	79	7	test	test	NOUN
dpc-92	79	8	.	.	PUNCT
dpc-92	80	1	the	the	DET
dpc-92	80	2	pearson	pearson	PROPN
dpc-92	80	3	correlation	correlation	NOUN
dpc-92	80	4	was	be	AUX
dpc-92	80	5	used	use	VERB
dpc-92	80	6	to	to	PART
dpc-92	80	7	assess	assess	VERB
dpc-92	80	8	the	the	DET
dpc-92	80	9	link	link	NOUN
dpc-92	80	10	between	between	ADP
dpc-92	80	11	dlqi	dlqi	PROPN
dpc-92	80	12	and	and	CCONJ
dpc-92	80	13	other	other	ADJ
dpc-92	80	14	secondary	secondary	ADJ
dpc-92	80	15	parameters	parameter	NOUN
dpc-92	80	16	.	.	PUNCT
dpc-92	81	1	p	p	X
dpc-92	81	2	-	-	PUNCT
dpc-92	81	3	value<0.05	value<0.05	NOUN
dpc-92	81	4	was	be	AUX
dpc-92	81	5	considered	consider	VERB
dpc-92	81	6	significant	significant	ADJ
dpc-92	81	7	.	.	PUNCT
dpc-92	82	1	results	result	VERB
dpc-92	82	2	sixty	sixty	NUM
dpc-92	82	3	-	-	PUNCT
dpc-92	82	4	eight	eight	NUM
dpc-92	82	5	patients	patient	NOUN
dpc-92	82	6	who	who	PRON
dpc-92	82	7	met	meet	VERB
dpc-92	82	8	study	study	NOUN
dpc-92	82	9	criteria	criterion	NOUN
dpc-92	82	10	were	be	AUX
dpc-92	82	11	randomly	randomly	ADV
dpc-92	82	12	assigned	assign	VERB
dpc-92	82	13	to	to	ADP
dpc-92	82	14	itraconazole	itraconazole	NOUN
dpc-92	82	15	and	and	CCONJ
dpc-92	82	16	placebo	placebo	NOUN
dpc-92	82	17	groups	group	NOUN
dpc-92	82	18	.	.	PUNCT
dpc-92	83	1	eleven	eleven	NUM
dpc-92	83	2	patients	patient	NOUN
dpc-92	83	3	were	be	AUX
dpc-92	83	4	lost	lose	VERB
dpc-92	83	5	to	to	PART
dpc-92	83	6	follow	follow	VERB
dpc-92	83	7	up	up	ADP
dpc-92	83	8	.	.	PUNCT
dpc-92	84	1	consequently	consequently	ADV
dpc-92	84	2	,	,	PUNCT
dpc-92	84	3	57	57	NUM
dpc-92	84	4	patients	patient	NOUN
dpc-92	84	5	completed	complete	VERB
dpc-92	84	6	the	the	DET
dpc-92	84	7	study	study	NOUN
dpc-92	84	8	and	and	CCONJ
dpc-92	84	9	were	be	AUX
dpc-92	84	10	included	include	VERB
dpc-92	84	11	in	in	ADP
dpc-92	84	12	the	the	DET
dpc-92	84	13	analysis	analysis	NOUN
dpc-92	84	14	(	(	PUNCT
dpc-92	84	15	figure	figure	NOUN
dpc-92	84	16	1	1	NUM
dpc-92	84	17	)	)	PUNCT
dpc-92	84	18	.	.	PUNCT
dpc-92	85	1	the	the	DET
dpc-92	85	2	main	main	ADJ
dpc-92	85	3	characteristics	characteristic	NOUN
dpc-92	85	4	of	of	ADP
dpc-92	85	5	patients	patient	NOUN
dpc-92	85	6	at	at	ADP
dpc-92	85	7	baseline	baseline	NOUN
dpc-92	85	8	and	and	CCONJ
dpc-92	85	9	at	at	ADP
dpc-92	85	10	the	the	DET
dpc-92	85	11	end	end	NOUN
dpc-92	85	12	of	of	ADP
dpc-92	85	13	study	study	NOUN
dpc-92	85	14	are	be	AUX
dpc-92	85	15	summarized	summarize	VERB
dpc-92	85	16	in	in	ADP
dpc-92	85	17	table	table	NOUN
dpc-92	85	18	1	1	NUM
dpc-92	85	19	.	.	PUNCT
dpc-92	86	1	the	the	DET
dpc-92	86	2	mean	mean	ADJ
dpc-92	86	3	dlqi	dlqi	ADJ
dpc-92	86	4	score	score	NOUN
dpc-92	86	5	in	in	ADP
dpc-92	86	6	our	our	PRON
dpc-92	86	7	study	study	NOUN
dpc-92	86	8	was	be	AUX
dpc-92	86	9	5.88±4.30	5.88±4.30	PROPN
dpc-92	86	10	.	.	PUNCT
dpc-92	87	1	although	although	SCONJ
dpc-92	87	2	dlqi	dlqi	PROPN
dpc-92	87	3	scores	score	NOUN
dpc-92	87	4	decreased	decrease	VERB
dpc-92	87	5	figure	figure	NOUN
dpc-92	87	6	2	2	NUM
dpc-92	87	7	.	.	PUNCT
dpc-92	87	8	comparison	comparison	NOUN
dpc-92	87	9	of	of	ADP
dpc-92	87	10	dlqi	dlqi	NOUN
dpc-92	87	11	before	before	ADV
dpc-92	87	12	and	and	CCONJ
dpc-92	87	13	after	after	ADP
dpc-92	87	14	treatment	treatment	NOUN
dpc-92	87	15	in	in	ADP
dpc-92	87	16	both	both	DET
dpc-92	87	17	groups	group	NOUN
dpc-92	87	18	.	.	PUNCT
dpc-92	88	1	[	[	X
dpc-92	88	2	copyright	copyright	NOUN
dpc-92	88	3	:	:	PUNCT
dpc-92	88	4	©	©	PROPN
dpc-92	88	5	2016	2016	NUM
dpc-92	88	6	abbas	abbas	PROPN
dpc-92	88	7	et	et	PROPN
dpc-92	88	8	al	al	PROPN
dpc-92	88	9	.	.	PROPN
dpc-92	88	10	]	]	PUNCT
dpc-92	88	11	figure	figure	NOUN
dpc-92	88	12	3	3	NUM
dpc-92	88	13	.	.	PUNCT
dpc-92	88	14	categories	category	NOUN
dpc-92	88	15	of	of	ADP
dpc-92	88	16	dlqi	dlqi	NOUN
dpc-92	88	17	and	and	CCONJ
dpc-92	88	18	comparison	comparison	NOUN
dpc-92	88	19	of	of	ADP
dpc-92	88	20	mean	mean	ADJ
dpc-92	88	21	score	score	NOUN
dpc-92	88	22	in	in	ADP
dpc-92	88	23	both	both	DET
dpc-92	88	24	groups	group	NOUN
dpc-92	88	25	(	(	PUNCT
dpc-92	88	26	left	left	ADJ
dpc-92	88	27	itraconazole	itraconazole	NOUN
dpc-92	88	28	,	,	PUNCT
dpc-92	88	29	right	right	ADJ
dpc-92	88	30	placebo	placebo	NOUN
dpc-92	88	31	)	)	PUNCT
dpc-92	88	32	.	.	PUNCT
dpc-92	89	1	[	[	X
dpc-92	89	2	copyright	copyright	NOUN
dpc-92	89	3	:	:	PUNCT
dpc-92	89	4	©	©	PROPN
dpc-92	89	5	2016	2016	NUM
dpc-92	89	6	abbas	abbas	PROPN
dpc-92	89	7	et	et	PROPN
dpc-92	89	8	al	al	PROPN
dpc-92	89	9	.	.	PROPN
dpc-92	89	10	]	]	PUNCT
dpc-92	90	1	research	research	NOUN
dpc-92	90	2	|	|	ADV
dpc-92	90	3	dermatol	dermatol	NOUN
dpc-92	90	4	pract	pract	NOUN
dpc-92	90	5	concept	concept	NOUN
dpc-92	90	6	2016;6(3):4	2016;6(3):4	PROPN
dpc-92	90	7	15	15	NUM
dpc-92	90	8	dramatically	dramatically	ADV
dpc-92	90	9	improve	improve	VERB
dpc-92	90	10	quality	quality	NOUN
dpc-92	90	11	of	of	ADP
dpc-92	90	12	life	life	NOUN
dpc-92	90	13	and	and	CCONJ
dpc-92	90	14	disease	disease	NOUN
dpc-92	90	15	severity	severity	NOUN
dpc-92	90	16	.	.	PUNCT
dpc-92	91	1	due	due	ADP
dpc-92	91	2	to	to	ADP
dpc-92	91	3	the	the	DET
dpc-92	91	4	complex	complex	ADJ
dpc-92	91	5	interactions	interaction	NOUN
dpc-92	91	6	among	among	ADP
dpc-92	91	7	diseases	disease	NOUN
dpc-92	91	8	,	,	PUNCT
dpc-92	91	9	the	the	DET
dpc-92	91	10	patients	patient	NOUN
dpc-92	91	11	’	'	PUNCT
dpc-92	91	12	qol	qol	NOUN
dpc-92	91	13	and	and	CCONJ
dpc-92	91	14	therapeutics	therapeutic	NOUN
dpc-92	91	15	,	,	PUNCT
dpc-92	91	16	physicians	physician	NOUN
dpc-92	91	17	must	must	AUX
dpc-92	91	18	couple	couple	VERB
dpc-92	91	19	subjective	subjective	ADJ
dpc-92	91	20	assessment	assessment	NOUN
dpc-92	91	21	of	of	ADP
dpc-92	91	22	qol	qol	PROPN
dpc-92	91	23	with	with	ADP
dpc-92	91	24	objective	objective	ADJ
dpc-92	91	25	measurements	measurement	NOUN
dpc-92	91	26	for	for	ADP
dpc-92	91	27	the	the	DET
dpc-92	91	28	proper	proper	ADJ
dpc-92	91	29	management	management	NOUN
dpc-92	91	30	of	of	ADP
dpc-92	91	31	severe	severe	ADJ
dpc-92	91	32	sd	sd	NOUN
dpc-92	91	33	.	.	PUNCT
dpc-92	92	1	trial	trial	NOUN
dpc-92	92	2	registration	registration	NOUN
dpc-92	92	3	:	:	PUNCT
dpc-92	92	4	irct2012091510842n1	irct2012091510842n1	PROPN
dpc-92	92	5	(	(	PUNCT
dpc-92	92	6	www.irct.ir	www.irct.ir	PROPN
dpc-92	92	7	)	)	PUNCT
dpc-92	92	8	acknowledgements	acknowledgement	NOUN
dpc-92	92	9	this	this	DET
dpc-92	92	10	study	study	NOUN
dpc-92	92	11	was	be	AUX
dpc-92	92	12	sponsored	sponsor	VERB
dpc-92	92	13	and	and	CCONJ
dpc-92	92	14	funded	fund	VERB
dpc-92	92	15	by	by	ADP
dpc-92	92	16	tehran	tehran	PROPN
dpc-92	92	17	university	university	PROPN
dpc-92	92	18	of	of	ADP
dpc-92	92	19	medical	medical	ADJ
dpc-92	92	20	sciences	science	NOUN
dpc-92	92	21	.	.	PUNCT
dpc-92	93	1	references	reference	NOUN
dpc-92	93	2	1	1	NUM
dpc-92	93	3	.	.	PUNCT
dpc-92	93	4	gupta	gupta	PROPN
dpc-92	93	5	ak	ak	PROPN
dpc-92	93	6	,	,	PUNCT
dpc-92	93	7	bluhm	bluhm	PROPN
dpc-92	93	8	r.	r.	PROPN
dpc-92	93	9	seborrheic	seborrheic	PROPN
dpc-92	93	10	dermatitis	dermatitis	PROPN
dpc-92	93	11	.	.	PUNCT
dpc-92	94	1	j	j	PROPN
dpc-92	94	2	eur	eur	PROPN
dpc-92	94	3	acad	acad	PROPN
dpc-92	94	4	dermatol	dermatol	NOUN
dpc-92	94	5	venereol	venereol	NOUN
dpc-92	94	6	2004;18:13	2004;18:13	NUM
dpc-92	94	7	-	-	SYM
dpc-92	94	8	26	26	NUM
dpc-92	94	9	.	.	PUNCT
dpc-92	95	1	pmid	pmid	NOUN
dpc-92	95	2	:	:	PUNCT
dpc-92	95	3	14678527	14678527	NUM
dpc-92	95	4	.	.	PUNCT
dpc-92	96	1	2	2	X
dpc-92	96	2	.	.	X
dpc-92	96	3	johnson	johnson	PROPN
dpc-92	96	4	ba	ba	PROPN
dpc-92	96	5	,	,	PUNCT
dpc-92	96	6	nunley	nunley	PROPN
dpc-92	96	7	jr	jr	PROPN
dpc-92	96	8	.	.	PROPN
dpc-92	96	9	treatment	treatment	NOUN
dpc-92	96	10	of	of	ADP
dpc-92	96	11	seborrheic	seborrheic	NUM
dpc-92	96	12	dermatitis	dermatitis	NOUN
dpc-92	96	13	.	.	PUNCT
dpc-92	97	1	am	be	AUX
dpc-92	97	2	fam	fam	NOUN
dpc-92	97	3	physician	physician	NOUN
dpc-92	97	4	2000;61:2703	2000;61:2703	NUM
dpc-92	97	5	-	-	SYM
dpc-92	97	6	2710	2710	NUM
dpc-92	97	7	,	,	PUNCT
dpc-92	97	8	2713	2713	NUM
dpc-92	97	9	-	-	SYM
dpc-92	97	10	2714	2714	NUM
dpc-92	97	11	.	.	PUNCT
dpc-92	98	1	pmid	pmid	NOUN
dpc-92	98	2	:	:	PUNCT
dpc-92	98	3	10821151	10821151	NUM
dpc-92	98	4	.	.	PUNCT
dpc-92	99	1	3	3	X
dpc-92	99	2	.	.	X
dpc-92	99	3	schwartz	schwartz	PROPN
dpc-92	99	4	ra	ra	PROPN
dpc-92	99	5	,	,	PUNCT
dpc-92	99	6	janusz	janusz	PROPN
dpc-92	99	7	ca	can	AUX
dpc-92	99	8	,	,	PUNCT
dpc-92	99	9	janniger	janniger	VERB
dpc-92	99	10	ck	ck	PROPN
dpc-92	99	11	.	.	PUNCT
dpc-92	100	1	seborrheic	seborrheic	PROPN
dpc-92	100	2	dermatitis	dermatitis	NOUN
dpc-92	100	3	:	:	PUNCT
dpc-92	100	4	an	an	DET
dpc-92	100	5	overview	overview	NOUN
dpc-92	100	6	.	.	PUNCT
dpc-92	101	1	am	be	AUX
dpc-92	101	2	fam	fam	NOUN
dpc-92	101	3	phys	phy	NOUN
dpc-92	101	4	2006;74:125	2006;74:125	NOUN
dpc-92	101	5	-	-	SYM
dpc-92	101	6	30	30	NUM
dpc-92	101	7	.	.	PUNCT
dpc-92	102	1	pmid	pmid	NOUN
dpc-92	102	2	:	:	PUNCT
dpc-92	102	3	16848386	16848386	NUM
dpc-92	102	4	.	.	PUNCT
dpc-92	103	1	4	4	X
dpc-92	103	2	.	.	X
dpc-92	103	3	szepietowski	szepietowski	PROPN
dpc-92	103	4	jc	jc	PROPN
dpc-92	103	5	,	,	PUNCT
dpc-92	103	6	reich	reich	PROPN
dpc-92	103	7	a	a	PRON
dpc-92	103	8	,	,	PUNCT
dpc-92	103	9	wesołowska	wesołowska	PROPN
dpc-92	103	10	szepietowska	szepietowska	PROPN
dpc-92	103	11	e	e	PROPN
dpc-92	103	12	,	,	PUNCT
dpc-92	103	13	baran	baran	PROPN
dpc-92	103	14	e.	e.	PROPN
dpc-92	103	15	national	national	PROPN
dpc-92	103	16	quality	quality	NOUN
dpc-92	103	17	of	of	ADP
dpc-92	103	18	life	life	NOUN
dpc-92	103	19	in	in	ADP
dpc-92	103	20	dermatology	dermatology	NOUN
dpc-92	103	21	group	group	NOUN
dpc-92	103	22	.	.	PUNCT
dpc-92	104	1	quality	quality	NOUN
dpc-92	104	2	of	of	ADP
dpc-92	104	3	life	life	NOUN
dpc-92	104	4	in	in	ADP
dpc-92	104	5	patients	patient	NOUN
dpc-92	104	6	suffering	suffer	VERB
dpc-92	104	7	from	from	ADP
dpc-92	104	8	seborrheic	seborrheic	ADJ
dpc-92	104	9	dermatitis	dermatitis	NOUN
dpc-92	104	10	:	:	PUNCT
dpc-92	104	11	influence	influence	NOUN
dpc-92	104	12	of	of	ADP
dpc-92	104	13	age	age	NOUN
dpc-92	104	14	,	,	PUNCT
dpc-92	104	15	gender	gender	NOUN
dpc-92	104	16	and	and	CCONJ
dpc-92	104	17	education	education	NOUN
dpc-92	104	18	level	level	NOUN
dpc-92	104	19	.	.	PUNCT
dpc-92	105	1	mycoses	mycose	NOUN
dpc-92	105	2	2009;52(4):357	2009;52(4):357	NUM
dpc-92	105	3	-	-	SYM
dpc-92	105	4	63	63	NUM
dpc-92	105	5	.	.	PUNCT
dpc-92	106	1	pmid	pmid	NOUN
dpc-92	106	2	:	:	PUNCT
dpc-92	106	3	18793259	18793259	NUM
dpc-92	106	4	doi	doi	NOUN
dpc-92	106	5	:	:	PUNCT
dpc-92	106	6	10.1111	10.1111	NUM
dpc-92	106	7	/	/	SYM
dpc-92	106	8	j.1439	j.1439	PROPN
dpc-92	106	9	-	-	PUNCT
dpc-92	106	10	0507.2008.01624.x	0507.2008.01624.x	PROPN
dpc-92	106	11	.	.	PUNCT
dpc-92	107	1	5	5	NUM
dpc-92	107	2	.	.	X
dpc-92	107	3	peyri	peyri	PROPN
dpc-92	107	4	j	j	PROPN
dpc-92	107	5	,	,	PUNCT
dpc-92	107	6	lleonart	lleonart	PROPN
dpc-92	107	7	m	m	PROPN
dpc-92	107	8	,	,	PUNCT
dpc-92	107	9	grupo	grupo	PROPN
dpc-92	107	10	español	español	PROPN
dpc-92	107	11	del	del	PROPN
dpc-92	107	12	studio	studio	PROPN
dpc-92	107	13	sebderm	sebderm	NOUN
dpc-92	107	14	.	.	PUNCT
dpc-92	108	1	clinical	clinical	ADJ
dpc-92	108	2	and	and	CCONJ
dpc-92	108	3	therapeutic	therapeutic	ADJ
dpc-92	108	4	profile	profile	NOUN
dpc-92	108	5	and	and	CCONJ
dpc-92	108	6	quality	quality	NOUN
dpc-92	108	7	of	of	ADP
dpc-92	108	8	life	life	NOUN
dpc-92	108	9	of	of	ADP
dpc-92	108	10	patients	patient	NOUN
dpc-92	108	11	with	with	ADP
dpc-92	108	12	seborrheic	seborrheic	PROPN
dpc-92	108	13	dermatitis	dermatitis	NOUN
dpc-92	108	14	.	.	PUNCT
dpc-92	109	1	actas	actas	PROPN
dpc-92	109	2	dermosifiliogr	dermosifiliogr	NOUN
dpc-92	109	3	2007;98(7):476	2007;98(7):476	PROPN
dpc-92	109	4	-	-	PUNCT
dpc-92	109	5	82	82	NUM
dpc-92	109	6	.	.	PUNCT
dpc-92	110	1	pmid	pmid	NOUN
dpc-92	110	2	:	:	PUNCT
dpc-92	110	3	17669302	17669302	NUM
dpc-92	110	4	.	.	PUNCT
dpc-92	111	1	6	6	X
dpc-92	111	2	.	.	X
dpc-92	111	3	oztas	oztas	PROPN
dpc-92	111	4	p	p	NOUN
dpc-92	111	5	,	,	PUNCT
dpc-92	111	6	calikoglu	calikoglu	NOUN
dpc-92	111	7	e	e	NOUN
dpc-92	111	8	,	,	PUNCT
dpc-92	111	9	cetin	cetin	PROPN
dpc-92	111	10	i.	i.	PROPN
dpc-92	111	11	psychiatric	psychiatric	PROPN
dpc-92	111	12	tests	test	NOUN
dpc-92	111	13	in	in	ADP
dpc-92	111	14	seborrhoeic	seborrhoeic	PROPN
dpc-92	111	15	dermatitis	dermatitis	PROPN
dpc-92	111	16	.	.	PUNCT
dpc-92	112	1	acta	acta	PROPN
dpc-92	112	2	derm	derm	PROPN
dpc-92	112	3	venereol	venereol	NOUN
dpc-92	112	4	2005;85(1):68	2005;85(1):68	NUM
dpc-92	112	5	-	-	SYM
dpc-92	112	6	9	9	NUM
dpc-92	112	7	.	.	PUNCT
dpc-92	113	1	pmid	pmid	NOUN
dpc-92	113	2	:	:	PUNCT
dpc-92	113	3	15848997	15848997	NUM
dpc-92	113	4	doi	doi	NOUN
dpc-92	113	5	:	:	PUNCT
dpc-92	113	6	10.1080/00015550410021574	10.1080/00015550410021574	NUM
dpc-92	113	7	.	.	PUNCT
dpc-92	114	1	7	7	X
dpc-92	114	2	.	.	PUNCT
dpc-92	114	3	baysal	baysal	PROPN
dpc-92	114	4	v	v	PROPN
dpc-92	114	5	,	,	PUNCT
dpc-92	114	6	yildirim	yildirim	PROPN
dpc-92	114	7	m	m	PROPN
dpc-92	114	8	,	,	PUNCT
dpc-92	114	9	ozcanli	ozcanli	PROPN
dpc-92	114	10	c	c	NOUN
dpc-92	114	11	,	,	PUNCT
dpc-92	114	12	ceyhan	ceyhan	PROPN
dpc-92	114	13	am	be	AUX
dpc-92	114	14	.	.	PUNCT
dpc-92	115	1	itraconazole	itraconazole	PROPN
dpc-92	115	2	in	in	ADP
dpc-92	115	3	the	the	DET
dpc-92	115	4	treatment	treatment	NOUN
dpc-92	115	5	of	of	ADP
dpc-92	115	6	seborrheic	seborrheic	PROPN
dpc-92	115	7	dermatitis	dermatitis	NOUN
dpc-92	115	8	:	:	PUNCT
dpc-92	115	9	a	a	DET
dpc-92	115	10	new	new	ADJ
dpc-92	115	11	treatment	treatment	NOUN
dpc-92	115	12	modality	modality	NOUN
dpc-92	115	13	.	.	PUNCT
dpc-92	116	1	int	int	NOUN
dpc-92	116	2	j	j	PROPN
dpc-92	116	3	dermatol	dermatol	NOUN
dpc-92	116	4	2004;43(1):63	2004;43(1):63	NUM
dpc-92	116	5	-	-	SYM
dpc-92	116	6	6	6	NUM
dpc-92	116	7	.	.	PUNCT
dpc-92	117	1	pmid	pmid	NOUN
dpc-92	117	2	:	:	PUNCT
dpc-92	117	3	14693026	14693026	NUM
dpc-92	117	4	.	.	PUNCT
dpc-92	118	1	10.1111	10.1111	NUM
dpc-92	118	2	/	/	SYM
dpc-92	118	3	j.13654632.2004.02123.x	j.13654632.2004.02123.x	PROPN
dpc-92	118	4	.	.	PUNCT
dpc-92	119	1	8	8	NUM
dpc-92	119	2	.	.	X
dpc-92	119	3	gupta	gupta	PROPN
dpc-92	119	4	ak	ak	PROPN
dpc-92	119	5	,	,	PUNCT
dpc-92	119	6	richardson	richardson	PROPN
dpc-92	119	7	m	m	PROPN
dpc-92	119	8	,	,	PUNCT
dpc-92	119	9	paquet	paquet	PROPN
dpc-92	119	10	m.	m.	NOUN
dpc-92	119	11	systemic	systemic	ADJ
dpc-92	119	12	review	review	NOUN
dpc-92	119	13	of	of	ADP
dpc-92	119	14	oral	oral	ADJ
dpc-92	119	15	treatments	treatment	NOUN
dpc-92	119	16	for	for	ADP
dpc-92	119	17	seborrheic	seborrheic	PROPN
dpc-92	119	18	dermatitis	dermatitis	NOUN
dpc-92	119	19	.	.	PUNCT
dpc-92	120	1	j	j	PROPN
dpc-92	120	2	eur	eur	PROPN
dpc-92	120	3	acad	acad	PROPN
dpc-92	120	4	dermatol	dermatol	NOUN
dpc-92	120	5	venereol	venereol	NOUN
dpc-92	120	6	2014;28(1):16	2014;28(1):16	PROPN
dpc-92	120	7	-	-	SYM
dpc-92	120	8	26	26	NUM
dpc-92	120	9	.	.	PUNCT
dpc-92	121	1	pmid	pmid	NOUN
dpc-92	121	2	:	:	PUNCT
dpc-92	121	3	23802806	23802806	NUM
dpc-92	121	4	doi	doi	NOUN
dpc-92	121	5	:	:	PUNCT
dpc-92	121	6	10.1111	10.1111	NUM
dpc-92	121	7	/	/	SYM
dpc-92	121	8	jdv.12197	jdv.12197	NUM
dpc-92	121	9	.	.	NOUN
dpc-92	121	10	9	9	NUM
dpc-92	121	11	.	.	X
dpc-92	122	1	kose	kose	PROPN
dpc-92	122	2	o	o	PROPN
dpc-92	122	3	,	,	PUNCT
dpc-92	122	4	erbil	erbil	PROPN
dpc-92	122	5	h	h	PROPN
dpc-92	122	6	,	,	PUNCT
dpc-92	122	7	gur	gur	PROPN
dpc-92	122	8	ar	ar	PROPN
dpc-92	122	9	.	.	PROPN
dpc-92	122	10	oral	oral	ADJ
dpc-92	122	11	itraconazole	itraconazole	NOUN
dpc-92	122	12	for	for	ADP
dpc-92	122	13	the	the	DET
dpc-92	122	14	treatment	treatment	NOUN
dpc-92	122	15	of	of	ADP
dpc-92	122	16	seborrhoeic	seborrhoeic	PROPN
dpc-92	122	17	dermatitis	dermatitis	NOUN
dpc-92	122	18	:	:	PUNCT
dpc-92	122	19	an	an	DET
dpc-92	122	20	open	open	ADJ
dpc-92	122	21	,	,	PUNCT
dpc-92	122	22	noncomparative	noncomparative	ADJ
dpc-92	122	23	trial	trial	NOUN
dpc-92	122	24	.	.	PUNCT
dpc-92	123	1	j	j	PROPN
dpc-92	123	2	eur	eur	PROPN
dpc-92	123	3	acad	acad	PROPN
dpc-92	123	4	dermatol	dermatol	NOUN
dpc-92	123	5	venereol	venereol	NOUN
dpc-92	123	6	2005	2005	NUM
dpc-92	123	7	;	;	PUNCT
dpc-92	123	8	19(2):172	19(2):172	NUM
dpc-92	123	9	-	-	SYM
dpc-92	123	10	5	5	NUM
dpc-92	123	11	.	.	PUNCT
dpc-92	123	12	pmid	pmid	NOUN
dpc-92	123	13	:	:	PUNCT
dpc-92	123	14	15752285	15752285	NUM
dpc-92	123	15	.	.	PUNCT
dpc-92	124	1	doi	doi	NOUN
dpc-92	124	2	:	:	PUNCT
dpc-92	124	3	10.1111	10.1111	NUM
dpc-92	124	4	/	/	SYM
dpc-92	124	5	j.1468	j.1468	NOUN
dpc-92	124	6	-	-	PUNCT
dpc-92	124	7	3083.2005.01090.x	3083.2005.01090.x	NUM
dpc-92	124	8	.	.	PUNCT
dpc-92	125	1	10	10	NUM
dpc-92	125	2	.	.	PUNCT
dpc-92	126	1	shemer	shemer	PROPN
dpc-92	126	2	a	a	PROPN
dpc-92	126	3	,	,	PUNCT
dpc-92	126	4	kaplan	kaplan	PROPN
dpc-92	126	5	b	b	PROPN
dpc-92	126	6	,	,	PUNCT
dpc-92	126	7	nathansohn	nathansohn	PROPN
dpc-92	126	8	n	n	INTJ
dpc-92	126	9	et	et	PROPN
dpc-92	126	10	al	al	PROPN
dpc-92	126	11	.	.	PROPN
dpc-92	126	12	treatment	treatment	NOUN
dpc-92	126	13	of	of	ADP
dpc-92	126	14	moderate	moderate	ADJ
dpc-92	126	15	to	to	ADP
dpc-92	126	16	severe	severe	ADJ
dpc-92	126	17	facial	facial	ADJ
dpc-92	126	18	seborrheic	seborrheic	ADJ
dpc-92	126	19	dermatitis	dermatitis	NOUN
dpc-92	126	20	with	with	ADP
dpc-92	126	21	itraconazole	itraconazole	PROPN
dpc-92	126	22	:	:	PUNCT
dpc-92	126	23	an	an	DET
dpc-92	126	24	open	open	ADJ
dpc-92	126	25	non	non	ADJ
dpc-92	126	26	-	-	ADJ
dpc-92	126	27	comparative	comparative	ADJ
dpc-92	126	28	study	study	NOUN
dpc-92	126	29	.	.	PUNCT
dpc-92	127	1	isr	isr	PROPN
dpc-92	127	2	med	med	PROPN
dpc-92	127	3	assoc	assoc	PROPN
dpc-92	127	4	j	j	PROPN
dpc-92	127	5	2008	2008	NUM
dpc-92	127	6	;	;	PUNCT
dpc-92	127	7	10(6):417	10(6):417	NUM
dpc-92	127	8	-	-	SYM
dpc-92	127	9	8	8	NUM
dpc-92	127	10	.	.	PUNCT
dpc-92	128	1	pmid	pmid	NOUN
dpc-92	128	2	:	:	PUNCT
dpc-92	128	3	18669136	18669136	NUM
dpc-92	128	4	.	.	PUNCT
dpc-92	129	1	11	11	NUM
dpc-92	129	2	.	.	PUNCT
dpc-92	130	1	das	das	PROPN
dpc-92	130	2	j	j	PROPN
dpc-92	130	3	,	,	PUNCT
dpc-92	130	4	majumdar	majumdar	PROPN
dpc-92	130	5	m	m	PROPN
dpc-92	130	6	,	,	PUNCT
dpc-92	130	7	chakraborty	chakraborty	PROPN
dpc-92	130	8	yu	yu	PROPN
dpc-92	130	9	,	,	PUNCT
dpc-92	130	10	et	et	PROPN
dpc-92	130	11	al	al	PROPN
dpc-92	130	12	.	.	PROPN
dpc-92	130	13	oral	oral	ADJ
dpc-92	130	14	itraconazole	itraconazole	NOUN
dpc-92	130	15	for	for	ADP
dpc-92	130	16	the	the	DET
dpc-92	130	17	treatment	treatment	NOUN
dpc-92	130	18	of	of	ADP
dpc-92	130	19	severe	severe	ADJ
dpc-92	130	20	seborrhoeic	seborrhoeic	ADJ
dpc-92	130	21	dermatitis	dermatitis	NOUN
dpc-92	130	22	.	.	PUNCT
dpc-92	131	1	indian	indian	PROPN
dpc-92	131	2	j	j	PROPN
dpc-92	131	3	dermatol	dermatol	NOUN
dpc-92	131	4	2011;56:515–6	2011;56:515–6	NUM
dpc-92	131	5	.	.	PUNCT
dpc-92	132	1	pmid	pmid	NOUN
dpc-92	132	2	:	:	PUNCT
dpc-92	132	3	22121267	22121267	NUM
dpc-92	132	4	.	.	PUNCT
dpc-92	133	1	doi	doi	NOUN
dpc-92	133	2	:	:	PUNCT
dpc-92	133	3	10.4103/00195154.87137	10.4103/00195154.87137	NUM
dpc-92	133	4	.	.	NOUN
dpc-92	133	5	12	12	NUM
dpc-92	133	6	.	.	PUNCT
dpc-92	134	1	comert	comert	PROPN
dpc-92	134	2	a	a	PRON
dpc-92	134	3	,	,	PUNCT
dpc-92	134	4	bekiroglu	bekiroglu	PROPN
dpc-92	134	5	n	n	CCONJ
dpc-92	134	6	,	,	PUNCT
dpc-92	134	7	gurbuz	gurbuz	NOUN
dpc-92	134	8	o	o	NOUN
dpc-92	134	9	,	,	PUNCT
dpc-92	134	10	ergun	ergun	NOUN
dpc-92	134	11	t.	t.	NOUN
dpc-92	134	12	efficacy	efficacy	NOUN
dpc-92	134	13	of	of	ADP
dpc-92	134	14	oral	oral	ADJ
dpc-92	134	15	fluconazole	fluconazole	NOUN
dpc-92	134	16	in	in	ADP
dpc-92	134	17	the	the	DET
dpc-92	134	18	treatment	treatment	NOUN
dpc-92	134	19	of	of	ADP
dpc-92	134	20	seborrheic	seborrheic	PROPN
dpc-92	134	21	dermatitis	dermatitis	NOUN
dpc-92	134	22	:	:	PUNCT
dpc-92	134	23	a	a	DET
dpc-92	134	24	placebocontrolled	placebocontrolle	VERB
dpc-92	134	25	study	study	NOUN
dpc-92	134	26	.	.	PUNCT
dpc-92	135	1	am	be	AUX
dpc-92	135	2	j	j	PROPN
dpc-92	135	3	clin	clin	PROPN
dpc-92	135	4	dermatol	dermatol	NOUN
dpc-92	135	5	2007;8(4):235	2007;8(4):235	NUM
dpc-92	135	6	-	-	SYM
dpc-92	135	7	8	8	NUM
dpc-92	135	8	.	.	PUNCT
dpc-92	136	1	pmid	pmid	NOUN
dpc-92	136	2	:	:	PUNCT
dpc-92	136	3	17645378	17645378	NUM
dpc-92	136	4	.	.	PUNCT
dpc-92	137	1	13	13	NUM
dpc-92	137	2	.	.	X
dpc-92	137	3	ghodsi	ghodsi	PROPN
dpc-92	137	4	sz	sz	PROPN
dpc-92	137	5	,	,	PUNCT
dpc-92	137	6	abbas	abbas	PROPN
dpc-92	137	7	z	z	PROPN
dpc-92	137	8	,	,	PUNCT
dpc-92	137	9	abedeni	abedeni	PROPN
dpc-92	137	10	r.	r.	PROPN
dpc-92	137	11	efficacy	efficacy	PROPN
dpc-92	137	12	of	of	ADP
dpc-92	137	13	oral	oral	ADJ
dpc-92	137	14	itraconazole	itraconazole	NOUN
dpc-92	137	15	in	in	ADP
dpc-92	137	16	the	the	DET
dpc-92	137	17	treatment	treatment	NOUN
dpc-92	137	18	and	and	CCONJ
dpc-92	137	19	relapse	relapse	NOUN
dpc-92	137	20	prevention	prevention	NOUN
dpc-92	137	21	of	of	ADP
dpc-92	137	22	moderate	moderate	ADJ
dpc-92	137	23	to	to	ADP
dpc-92	137	24	severe	severe	ADJ
dpc-92	137	25	seborrheic	seborrheic	PROPN
dpc-92	137	26	dermatitis	dermatitis	NOUN
dpc-92	137	27	:	:	PUNCT
dpc-92	137	28	a	a	DET
dpc-92	137	29	randomized	randomized	ADJ
dpc-92	137	30	,	,	PUNCT
dpc-92	137	31	placebo	placebo	NOUN
dpc-92	137	32	-	-	PUNCT
dpc-92	137	33	controlled	control	VERB
dpc-92	137	34	trial	trial	NOUN
dpc-92	137	35	.	.	PUNCT
dpc-92	138	1	am	be	AUX
dpc-92	138	2	j	j	PROPN
dpc-92	138	3	clin	clin	PROPN
dpc-92	138	4	the	the	DET
dpc-92	138	5	mean	mean	ADJ
dpc-92	138	6	dlqi	dlqi	ADJ
dpc-92	138	7	score	score	NOUN
dpc-92	138	8	in	in	ADP
dpc-92	138	9	our	our	PRON
dpc-92	138	10	study	study	NOUN
dpc-92	138	11	was	be	AUX
dpc-92	138	12	similar	similar	ADJ
dpc-92	138	13	to	to	ADP
dpc-92	138	14	harlow	harlow	PROPN
dpc-92	138	15	et	et	PROPN
dpc-92	138	16	al	al	PROPN
dpc-92	138	17	(	(	PUNCT
dpc-92	138	18	mean	mean	PROPN
dpc-92	138	19	dlqi	dlqi	ADJ
dpc-92	138	20	:	:	PUNCT
dpc-92	138	21	5.9	5.9	NUM
dpc-92	138	22	,	,	PUNCT
dpc-92	138	23	n=20	n=20	PROPN
dpc-92	138	24	)	)	PUNCT
dpc-92	139	1	[	[	X
dpc-92	139	2	15	15	NUM
dpc-92	139	3	]	]	PUNCT
dpc-92	139	4	but	but	CCONJ
dpc-92	139	5	lower	low	ADJ
dpc-92	139	6	than	than	ADP
dpc-92	139	7	szepietowski	szepietowski	NOUN
dpc-92	139	8	et	et	PROPN
dpc-92	139	9	al	al	PROPN
dpc-92	139	10	(	(	PUNCT
dpc-92	139	11	mean	mean	PROPN
dpc-92	139	12	6.92±5.34	6.92±5.34	NOUN
dpc-92	139	13	)	)	PUNCT
dpc-92	140	1	[	[	X
dpc-92	140	2	4	4	NUM
dpc-92	140	3	]	]	PUNCT
dpc-92	140	4	.	.	PUNCT
dpc-92	141	1	the	the	DET
dpc-92	141	2	difference	difference	NOUN
dpc-92	141	3	could	could	AUX
dpc-92	141	4	be	be	AUX
dpc-92	141	5	explained	explain	VERB
dpc-92	141	6	by	by	ADP
dpc-92	141	7	the	the	DET
dpc-92	141	8	different	different	ADJ
dpc-92	141	9	regional	regional	ADJ
dpc-92	141	10	and	and	CCONJ
dpc-92	141	11	social	social	ADJ
dpc-92	141	12	backgrounds	background	NOUN
dpc-92	141	13	and	and	CCONJ
dpc-92	141	14	disease	disease	NOUN
dpc-92	141	15	severity	severity	NOUN
dpc-92	141	16	level	level	NOUN
dpc-92	141	17	in	in	ADP
dpc-92	141	18	these	these	DET
dpc-92	141	19	studies	study	NOUN
dpc-92	141	20	.	.	PUNCT
dpc-92	142	1	there	there	PRON
dpc-92	142	2	is	be	VERB
dpc-92	142	3	marked	mark	VERB
dpc-92	142	4	impairment	impairment	NOUN
dpc-92	142	5	of	of	ADP
dpc-92	142	6	qol	qol	NOUN
dpc-92	142	7	in	in	ADP
dpc-92	142	8	patients	patient	NOUN
dpc-92	142	9	with	with	ADP
dpc-92	142	10	more	more	ADV
dpc-92	142	11	severe	severe	ADJ
dpc-92	142	12	disease	disease	NOUN
dpc-92	142	13	,	,	PUNCT
dpc-92	142	14	with	with	ADP
dpc-92	142	15	a	a	DET
dpc-92	142	16	greater	great	ADJ
dpc-92	142	17	effect	effect	NOUN
dpc-92	142	18	observed	observe	VERB
dpc-92	142	19	in	in	ADP
dpc-92	142	20	women	woman	NOUN
dpc-92	142	21	and	and	CCONJ
dpc-92	142	22	in	in	ADP
dpc-92	142	23	young	young	ADJ
dpc-92	142	24	patients	patient	NOUN
dpc-92	142	25	(	(	PUNCT
dpc-92	142	26	age	age	NOUN
dpc-92	142	27	subgroup	subgroup	NOUN
dpc-92	142	28	:	:	PUNCT
dpc-92	142	29	26	26	NUM
dpc-92	142	30	-	-	SYM
dpc-92	142	31	35	35	NUM
dpc-92	142	32	years	year	NOUN
dpc-92	142	33	)	)	PUNCT
dpc-92	142	34	with	with	ADP
dpc-92	142	35	higher	high	ADJ
dpc-92	142	36	educational	educational	ADJ
dpc-92	142	37	level	level	NOUN
dpc-92	142	38	(	(	PUNCT
dpc-92	142	39	master	master	NOUN
dpc-92	142	40	and	and	CCONJ
dpc-92	142	41	phd	phd	NOUN
dpc-92	142	42	level	level	NOUN
dpc-92	142	43	)	)	PUNCT
dpc-92	142	44	,	,	PUNCT
dpc-92	142	45	and	and	CCONJ
dpc-92	142	46	this	this	PRON
dpc-92	142	47	is	be	AUX
dpc-92	142	48	almost	almost	ADV
dpc-92	142	49	parallel	parallel	ADJ
dpc-92	142	50	to	to	ADP
dpc-92	142	51	previous	previous	ADJ
dpc-92	142	52	studies	study	NOUN
dpc-92	142	53	[	[	X
dpc-92	142	54	4	4	NUM
dpc-92	142	55	-	-	SYM
dpc-92	142	56	5	5	NUM
dpc-92	142	57	]	]	PUNCT
dpc-92	142	58	.	.	PUNCT
dpc-92	143	1	interestingly	interestingly	ADV
dpc-92	143	2	,	,	PUNCT
dpc-92	143	3	in	in	ADP
dpc-92	143	4	our	our	PRON
dpc-92	143	5	study	study	NOUN
dpc-92	143	6	,	,	PUNCT
dpc-92	143	7	disease	disease	NOUN
dpc-92	143	8	duration	duration	NOUN
dpc-92	143	9	and	and	CCONJ
dpc-92	143	10	number	number	NOUN
dpc-92	143	11	of	of	ADP
dpc-92	143	12	relapses	relapse	NOUN
dpc-92	143	13	had	have	VERB
dpc-92	143	14	no	no	DET
dpc-92	143	15	effect	effect	NOUN
dpc-92	143	16	on	on	ADP
dpc-92	143	17	qol	qol	NOUN
dpc-92	143	18	.	.	PUNCT
dpc-92	144	1	here	here	ADV
dpc-92	144	2	,	,	PUNCT
dpc-92	144	3	adaptations	adaptation	NOUN
dpc-92	144	4	of	of	ADP
dpc-92	144	5	the	the	DET
dpc-92	144	6	patients	patient	NOUN
dpc-92	144	7	to	to	ADP
dpc-92	144	8	the	the	DET
dpc-92	144	9	nature	nature	NOUN
dpc-92	144	10	of	of	ADP
dpc-92	144	11	their	their	PRON
dpc-92	144	12	disease	disease	NOUN
dpc-92	144	13	and	and	CCONJ
dpc-92	144	14	coping	cope	VERB
dpc-92	144	15	more	more	ADV
dpc-92	144	16	efficiently	efficiently	ADV
dpc-92	144	17	with	with	ADP
dpc-92	144	18	the	the	DET
dpc-92	144	19	disease	disease	NOUN
dpc-92	144	20	and	and	CCONJ
dpc-92	144	21	therapies	therapy	NOUN
dpc-92	144	22	over	over	ADP
dpc-92	144	23	a	a	DET
dpc-92	144	24	certain	certain	ADJ
dpc-92	144	25	period	period	NOUN
dpc-92	144	26	of	of	ADP
dpc-92	144	27	time	time	NOUN
dpc-92	144	28	may	may	AUX
dpc-92	144	29	have	have	AUX
dpc-92	144	30	had	have	VERB
dpc-92	144	31	effect	effect	NOUN
dpc-92	144	32	.	.	PUNCT
dpc-92	145	1	the	the	DET
dpc-92	145	2	most	most	ADV
dpc-92	145	3	common	common	ADJ
dpc-92	145	4	site	site	NOUN
dpc-92	145	5	involved	involve	VERB
dpc-92	145	6	in	in	ADP
dpc-92	145	7	our	our	PRON
dpc-92	145	8	study	study	NOUN
dpc-92	145	9	was	be	AUX
dpc-92	145	10	the	the	DET
dpc-92	145	11	scalp	scalp	NOUN
dpc-92	145	12	,	,	PUNCT
dpc-92	145	13	but	but	CCONJ
dpc-92	145	14	qol	qol	PRON
dpc-92	145	15	impairment	impairment	NOUN
dpc-92	145	16	was	be	AUX
dpc-92	145	17	higher	high	ADJ
dpc-92	145	18	significantly	significantly	ADV
dpc-92	145	19	in	in	ADP
dpc-92	145	20	facial	facial	ADJ
dpc-92	145	21	disease	disease	NOUN
dpc-92	145	22	.	.	PUNCT
dpc-92	146	1	as	as	SCONJ
dpc-92	146	2	the	the	DET
dpc-92	146	3	appearance	appearance	NOUN
dpc-92	146	4	plays	play	VERB
dpc-92	146	5	important	important	ADJ
dpc-92	146	6	role	role	NOUN
dpc-92	146	7	in	in	ADP
dpc-92	146	8	the	the	DET
dpc-92	146	9	society	society	NOUN
dpc-92	146	10	,	,	PUNCT
dpc-92	146	11	a	a	DET
dpc-92	146	12	patient	patient	NOUN
dpc-92	146	13	with	with	ADP
dpc-92	146	14	a	a	DET
dpc-92	146	15	red	red	ADJ
dpc-92	146	16	and	and	CCONJ
dpc-92	146	17	flaky	flaky	ADJ
dpc-92	146	18	face	face	NOUN
dpc-92	146	19	may	may	AUX
dpc-92	146	20	feel	feel	VERB
dpc-92	146	21	more	more	ADV
dpc-92	146	22	embarrassed	embarrassed	ADJ
dpc-92	146	23	.	.	PUNCT
dpc-92	147	1	the	the	DET
dpc-92	147	2	assessment	assessment	NOUN
dpc-92	147	3	of	of	ADP
dpc-92	147	4	the	the	DET
dpc-92	147	5	impact	impact	NOUN
dpc-92	147	6	on	on	ADP
dpc-92	147	7	quality	quality	NOUN
dpc-92	147	8	of	of	ADP
dpc-92	147	9	life	life	NOUN
dpc-92	147	10	in	in	ADP
dpc-92	147	11	patients	patient	NOUN
dpc-92	147	12	with	with	ADP
dpc-92	147	13	skin	skin	NOUN
dpc-92	147	14	diseases	disease	NOUN
dpc-92	147	15	is	be	AUX
dpc-92	147	16	important	important	ADJ
dpc-92	147	17	for	for	ADP
dpc-92	147	18	clinical	clinical	ADJ
dpc-92	147	19	management	management	NOUN
dpc-92	147	20	.	.	PUNCT
dpc-92	148	1	it	it	PRON
dpc-92	148	2	is	be	AUX
dpc-92	148	3	essential	essential	ADJ
dpc-92	148	4	to	to	PART
dpc-92	148	5	detect	detect	VERB
dpc-92	148	6	patients	patient	NOUN
dpc-92	148	7	at	at	ADP
dpc-92	148	8	a	a	DET
dpc-92	148	9	higher	high	ADJ
dpc-92	148	10	risk	risk	NOUN
dpc-92	148	11	of	of	ADP
dpc-92	148	12	experiencing	experience	VERB
dpc-92	148	13	a	a	DET
dpc-92	148	14	worse	bad	ADJ
dpc-92	148	15	quality	quality	NOUN
dpc-92	148	16	of	of	ADP
dpc-92	148	17	life	life	NOUN
dpc-92	148	18	in	in	ADP
dpc-92	148	19	order	order	NOUN
dpc-92	148	20	to	to	PART
dpc-92	148	21	treat	treat	VERB
dpc-92	148	22	him	he	PRON
dpc-92	148	23	/	/	SYM
dpc-92	148	24	her	she	PRON
dpc-92	148	25	in	in	ADP
dpc-92	148	26	a	a	DET
dpc-92	148	27	more	more	ADV
dpc-92	148	28	integrated	integrated	ADJ
dpc-92	148	29	way	way	NOUN
dpc-92	148	30	.	.	PUNCT
dpc-92	149	1	to	to	ADP
dpc-92	149	2	our	our	PRON
dpc-92	149	3	knowledge	knowledge	NOUN
dpc-92	149	4	,	,	PUNCT
dpc-92	149	5	this	this	DET
dpc-92	149	6	trial	trial	NOUN
dpc-92	149	7	was	be	AUX
dpc-92	149	8	the	the	DET
dpc-92	149	9	first	first	ADJ
dpc-92	149	10	using	use	VERB
dpc-92	149	11	a	a	DET
dpc-92	149	12	randomized	randomized	ADJ
dpc-92	149	13	,	,	PUNCT
dpc-92	149	14	placebo	placebo	NOUN
dpc-92	149	15	-	-	PUNCT
dpc-92	149	16	controlled	control	VERB
dpc-92	149	17	design	design	NOUN
dpc-92	149	18	that	that	PRON
dpc-92	149	19	investigated	investigate	VERB
dpc-92	149	20	the	the	DET
dpc-92	149	21	effect	effect	NOUN
dpc-92	149	22	of	of	ADP
dpc-92	149	23	itraconazole	itraconazole	NOUN
dpc-92	149	24	on	on	ADP
dpc-92	149	25	the	the	DET
dpc-92	149	26	quality	quality	NOUN
dpc-92	149	27	of	of	ADP
dpc-92	149	28	life	life	NOUN
dpc-92	149	29	in	in	ADP
dpc-92	149	30	moderate	moderate	ADJ
dpc-92	149	31	to	to	ADP
dpc-92	149	32	severe	severe	ADJ
dpc-92	149	33	sd	sd	ADP
dpc-92	149	34	patients	patient	NOUN
dpc-92	149	35	.	.	PUNCT
dpc-92	150	1	therapeutic	therapeutic	ADJ
dpc-92	150	2	efficacy	efficacy	NOUN
dpc-92	150	3	of	of	ADP
dpc-92	150	4	itraconazole	itraconazole	PROPN
dpc-92	150	5	has	have	AUX
dpc-92	150	6	already	already	ADV
dpc-92	150	7	been	be	AUX
dpc-92	150	8	studied	study	VERB
dpc-92	150	9	in	in	ADP
dpc-92	150	10	many	many	ADJ
dpc-92	150	11	previous	previous	ADJ
dpc-92	150	12	clinical	clinical	ADJ
dpc-92	150	13	trials	trial	NOUN
dpc-92	150	14	[	[	X
dpc-92	150	15	7	7	NUM
dpc-92	150	16	,	,	PUNCT
dpc-92	150	17	9	9	NUM
dpc-92	150	18	-	-	SYM
dpc-92	150	19	11	11	NUM
dpc-92	150	20	,	,	PUNCT
dpc-92	150	21	13	13	NUM
dpc-92	150	22	]	]	PUNCT
dpc-92	150	23	.	.	PUNCT
dpc-92	151	1	although	although	SCONJ
dpc-92	151	2	study	study	NOUN
dpc-92	151	3	designs	design	NOUN
dpc-92	151	4	and	and	CCONJ
dpc-92	151	5	measurement	measurement	NOUN
dpc-92	151	6	scales	scale	NOUN
dpc-92	151	7	were	be	AUX
dpc-92	151	8	different	different	ADJ
dpc-92	151	9	,	,	PUNCT
dpc-92	151	10	the	the	DET
dpc-92	151	11	results	result	NOUN
dpc-92	151	12	regarding	regard	VERB
dpc-92	151	13	effect	effect	NOUN
dpc-92	151	14	of	of	ADP
dpc-92	151	15	itraconazole	itraconazole	NOUN
dpc-92	151	16	were	be	AUX
dpc-92	151	17	almost	almost	ADV
dpc-92	151	18	similar	similar	ADJ
dpc-92	151	19	in	in	ADP
dpc-92	151	20	these	these	DET
dpc-92	151	21	studies	study	NOUN
dpc-92	151	22	,	,	PUNCT
dpc-92	151	23	and	and	CCONJ
dpc-92	151	24	this	this	DET
dpc-92	151	25	fact	fact	NOUN
dpc-92	151	26	shows	show	VERB
dpc-92	151	27	the	the	DET
dpc-92	151	28	marked	mark	VERB
dpc-92	151	29	efficacy	efficacy	NOUN
dpc-92	151	30	of	of	ADP
dpc-92	151	31	itraconazole	itraconazole	NOUN
dpc-92	151	32	in	in	ADP
dpc-92	151	33	the	the	DET
dpc-92	151	34	treatment	treatment	NOUN
dpc-92	151	35	of	of	ADP
dpc-92	151	36	severe	severe	ADJ
dpc-92	151	37	sd	sd	NOUN
dpc-92	151	38	.	.	PUNCT
dpc-92	152	1	our	our	PRON
dpc-92	152	2	study	study	NOUN
dpc-92	152	3	met	meet	VERB
dpc-92	152	4	with	with	ADP
dpc-92	152	5	several	several	ADJ
dpc-92	152	6	limitations	limitation	NOUN
dpc-92	152	7	.	.	PUNCT
dpc-92	153	1	first	first	ADV
dpc-92	153	2	,	,	PUNCT
dpc-92	153	3	no	no	DET
dpc-92	153	4	fungal	fungal	ADJ
dpc-92	153	5	culture	culture	NOUN
dpc-92	153	6	was	be	AUX
dpc-92	153	7	performed	perform	VERB
dpc-92	153	8	and	and	CCONJ
dpc-92	153	9	therefore	therefore	ADV
dpc-92	153	10	clinical	clinical	ADJ
dpc-92	153	11	outcome	outcome	NOUN
dpc-92	153	12	could	could	AUX
dpc-92	153	13	not	not	PART
dpc-92	153	14	be	be	AUX
dpc-92	153	15	correlated	correlate	VERB
dpc-92	153	16	directly	directly	ADV
dpc-92	153	17	to	to	ADP
dpc-92	153	18	malassezia	malassezia	NOUN
dpc-92	153	19	colonization	colonization	NOUN
dpc-92	153	20	.	.	PUNCT
dpc-92	154	1	second	second	ADV
dpc-92	154	2	,	,	PUNCT
dpc-92	154	3	the	the	DET
dpc-92	154	4	power	power	NOUN
dpc-92	154	5	of	of	ADP
dpc-92	154	6	the	the	DET
dpc-92	154	7	study	study	NOUN
dpc-92	154	8	is	be	AUX
dpc-92	154	9	limited	limit	VERB
dpc-92	154	10	by	by	ADP
dpc-92	154	11	the	the	DET
dpc-92	154	12	monocentric	monocentric	ADJ
dpc-92	154	13	design	design	NOUN
dpc-92	154	14	and	and	CCONJ
dpc-92	154	15	small	small	ADJ
dpc-92	154	16	sample	sample	NOUN
dpc-92	154	17	size	size	NOUN
dpc-92	154	18	of	of	ADP
dpc-92	154	19	our	our	PRON
dpc-92	154	20	study	study	NOUN
dpc-92	154	21	,	,	PUNCT
dpc-92	154	22	therefore	therefore	ADV
dpc-92	154	23	,	,	PUNCT
dpc-92	154	24	a	a	DET
dpc-92	154	25	larger	large	ADJ
dpc-92	154	26	,	,	PUNCT
dpc-92	154	27	multicentric	multicentric	ADJ
dpc-92	154	28	study	study	NOUN
dpc-92	154	29	is	be	AUX
dpc-92	154	30	warranted	warrant	VERB
dpc-92	154	31	to	to	PART
dpc-92	154	32	evaluate	evaluate	VERB
dpc-92	154	33	the	the	DET
dpc-92	154	34	therapeutic	therapeutic	ADJ
dpc-92	154	35	effect	effect	NOUN
dpc-92	154	36	of	of	ADP
dpc-92	154	37	itraconazole	itraconazole	NOUN
dpc-92	154	38	or	or	CCONJ
dpc-92	154	39	other	other	ADJ
dpc-92	154	40	newer	new	ADJ
dpc-92	154	41	therapies	therapy	NOUN
dpc-92	154	42	for	for	ADP
dpc-92	154	43	sd	sd	NOUN
dpc-92	154	44	patients	patient	NOUN
dpc-92	154	45	.	.	PUNCT
dpc-92	155	1	third	third	ADV
dpc-92	155	2	,	,	PUNCT
dpc-92	155	3	the	the	DET
dpc-92	155	4	short	short	ADJ
dpc-92	155	5	period	period	NOUN
dpc-92	155	6	of	of	ADP
dpc-92	155	7	follow	follow	VERB
dpc-92	155	8	up	up	ADV
dpc-92	155	9	;	;	PUNCT
dpc-92	155	10	a	a	DET
dpc-92	155	11	longer	long	ADJ
dpc-92	155	12	study	study	NOUN
dpc-92	155	13	period	period	NOUN
dpc-92	155	14	would	would	AUX
dpc-92	155	15	have	have	AUX
dpc-92	155	16	been	be	AUX
dpc-92	155	17	beneficial	beneficial	ADJ
dpc-92	155	18	.	.	PUNCT
dpc-92	156	1	fourth	fourth	ADJ
dpc-92	156	2	,	,	PUNCT
dpc-92	156	3	it	it	PRON
dpc-92	156	4	is	be	AUX
dpc-92	156	5	well	well	ADV
dpc-92	156	6	known	know	VERB
dpc-92	156	7	that	that	SCONJ
dpc-92	156	8	sd	sd	NOUN
dpc-92	156	9	may	may	AUX
dpc-92	156	10	worsen	worsen	VERB
dpc-92	156	11	or	or	CCONJ
dpc-92	156	12	improve	improve	VERB
dpc-92	156	13	due	due	ADJ
dpc-92	156	14	to	to	ADP
dpc-92	156	15	many	many	ADJ
dpc-92	156	16	factors	factor	NOUN
dpc-92	156	17	such	such	ADJ
dpc-92	156	18	as	as	ADP
dpc-92	156	19	seasonal	seasonal	ADJ
dpc-92	156	20	variation	variation	NOUN
dpc-92	156	21	,	,	PUNCT
dpc-92	156	22	host	host	NOUN
dpc-92	156	23	immunity	immunity	NOUN
dpc-92	156	24	,	,	PUNCT
dpc-92	156	25	and	and	CCONJ
dpc-92	156	26	host	host	NOUN
dpc-92	156	27	mood	mood	NOUN
dpc-92	156	28	status	status	NOUN
dpc-92	156	29	;	;	PUNCT
dpc-92	156	30	these	these	DET
dpc-92	156	31	factors	factor	NOUN
dpc-92	156	32	might	might	AUX
dpc-92	156	33	have	have	AUX
dpc-92	156	34	changed	change	VERB
dpc-92	156	35	the	the	DET
dpc-92	156	36	clinical	clinical	ADJ
dpc-92	156	37	condition	condition	NOUN
dpc-92	156	38	in	in	ADP
dpc-92	156	39	some	some	DET
dpc-92	156	40	patients	patient	NOUN
dpc-92	156	41	.	.	PUNCT
dpc-92	157	1	fifth	fifth	ADJ
dpc-92	157	2	,	,	PUNCT
dpc-92	157	3	although	although	SCONJ
dpc-92	157	4	the	the	DET
dpc-92	157	5	effect	effect	NOUN
dpc-92	157	6	of	of	ADP
dpc-92	157	7	topical	topical	ADJ
dpc-92	157	8	therapy	therapy	NOUN
dpc-92	157	9	declined	decline	VERB
dpc-92	157	10	mainly	mainly	ADV
dpc-92	157	11	after	after	ADP
dpc-92	157	12	two	two	NUM
dpc-92	157	13	weeks	week	NOUN
dpc-92	157	14	,	,	PUNCT
dpc-92	157	15	it	it	PRON
dpc-92	157	16	might	might	AUX
dpc-92	157	17	have	have	AUX
dpc-92	157	18	affected	affect	VERB
dpc-92	157	19	partly	partly	ADV
dpc-92	157	20	over	over	ADP
dpc-92	157	21	the	the	DET
dpc-92	157	22	final	final	ADJ
dpc-92	157	23	result	result	NOUN
dpc-92	157	24	of	of	ADP
dpc-92	157	25	clinical	clinical	ADJ
dpc-92	157	26	picture	picture	NOUN
dpc-92	157	27	and	and	CCONJ
dpc-92	157	28	dlqi	dlqi	NOUN
dpc-92	157	29	.	.	PUNCT
dpc-92	158	1	conclusions	conclusion	NOUN
dpc-92	158	2	sd	sd	ADV
dpc-92	158	3	can	can	AUX
dpc-92	158	4	significantly	significantly	ADV
dpc-92	158	5	reduce	reduce	VERB
dpc-92	158	6	qol	qol	NOUN
dpc-92	158	7	particularly	particularly	ADV
dpc-92	158	8	in	in	ADP
dpc-92	158	9	severe	severe	ADJ
dpc-92	158	10	disease	disease	NOUN
dpc-92	158	11	and	and	CCONJ
dpc-92	158	12	facial	facial	ADJ
dpc-92	158	13	involvement	involvement	NOUN
dpc-92	158	14	.	.	PUNCT
dpc-92	159	1	pulse	pulse	NOUN
dpc-92	159	2	therapy	therapy	NOUN
dpc-92	159	3	with	with	ADP
dpc-92	159	4	itraconazole	itraconazole	NOUN
dpc-92	159	5	can	can	AUX
dpc-92	159	6	http://www.irct.ir/searchresult.php?id=10842&number=1	http://www.irct.ir/searchresult.php?id=10842&number=1	PROPN
dpc-92	159	7	http://www.irct.ir	http://www.irct.ir	VERB
dpc-92	159	8	16	16	NUM
dpc-92	159	9	research	research	NOUN
dpc-92	159	10	|	|	ADV
dpc-92	159	11	dermatol	dermatol	NOUN
dpc-92	159	12	pract	pract	NOUN
dpc-92	159	13	concept	concept	NOUN
dpc-92	159	14	2016;6(3):4	2016;6(3):4	PROPN
dpc-92	159	15	15	15	NUM
dpc-92	159	16	.	.	PUNCT
dpc-92	160	1	harlow	harlow	PROPN
dpc-92	160	2	d	d	PROPN
dpc-92	160	3	,	,	PUNCT
dpc-92	160	4	poyner	poyner	NOUN
dpc-92	160	5	t	t	PROPN
dpc-92	160	6	,	,	PUNCT
dpc-92	160	7	finlay	finlay	VERB
dpc-92	160	8	ay	ay	NOUN
dpc-92	160	9	,	,	PUNCT
dpc-92	160	10	dykes	dyke	VERB
dpc-92	160	11	pj	pj	PROPN
dpc-92	160	12	.	.	PUNCT
dpc-92	160	13	impaired	impair	VERB
dpc-92	160	14	quality	quality	NOUN
dpc-92	160	15	of	of	ADP
dpc-92	160	16	life	life	NOUN
dpc-92	160	17	of	of	ADP
dpc-92	160	18	adults	adult	NOUN
dpc-92	160	19	with	with	ADP
dpc-92	160	20	skin	skin	NOUN
dpc-92	160	21	disease	disease	NOUN
dpc-92	160	22	in	in	ADP
dpc-92	160	23	primary	primary	ADJ
dpc-92	160	24	care	care	NOUN
dpc-92	160	25	.	.	PUNCT
dpc-92	161	1	br	br	PROPN
dpc-92	161	2	j	j	PROPN
dpc-92	161	3	dermatol	dermatol	NOUN
dpc-92	161	4	.	.	PUNCT
dpc-92	162	1	2000;143(5):979	2000;143(5):979	NUM
dpc-92	162	2	-	-	SYM
dpc-92	162	3	82.pmid	82.pmid	NUM
dpc-92	162	4	:	:	PUNCT
dpc-92	162	5	11069506	11069506	NUM
dpc-92	162	6	.	.	PUNCT
dpc-92	163	1	10.1046	10.1046	NUM
dpc-92	163	2	/	/	SYM
dpc-92	163	3	j.13652133.2000.03830.x	j.13652133.2000.03830.x	NOUN
dpc-92	163	4	.	.	PUNCT
dpc-92	164	1	dermatol	dermatol	NOUN
dpc-92	164	2	2015;16(5):431	2015;16(5):431	NUM
dpc-92	164	3	-	-	SYM
dpc-92	164	4	7	7	NUM
dpc-92	164	5	.	.	PUNCT
dpc-92	165	1	pmid	pmid	NOUN
dpc-92	165	2	:	:	PUNCT
dpc-92	165	3	26016699	26016699	NUM
dpc-92	165	4	.	.	PUNCT
dpc-92	166	1	doi	doi	NOUN
dpc-92	166	2	:	:	PUNCT
dpc-92	166	3	10.1007/	10.1007/	NUM
dpc-92	166	4	s40257	s40257	PROPN
dpc-92	166	5	-	-	PUNCT
dpc-92	166	6	015	015	NUM
dpc-92	166	7	-	-	PUNCT
dpc-92	166	8	0133	0133	NUM
dpc-92	166	9	-	-	SYM
dpc-92	166	10	9	9	NUM
dpc-92	166	11	.	.	NOUN
dpc-92	166	12	14	14	NUM
dpc-92	166	13	.	.	PUNCT
dpc-92	167	1	lewis	lewis	PROPN
dpc-92	167	2	v	v	PROPN
dpc-92	167	3	,	,	PUNCT
dpc-92	167	4	finlay	finlay	VERB
dpc-92	167	5	ay	ay	NOUN
dpc-92	167	6	.	.	PROPN
dpc-92	167	7	10	10	NUM
dpc-92	167	8	years	year	NOUN
dpc-92	167	9	experience	experience	NOUN
dpc-92	167	10	of	of	ADP
dpc-92	167	11	the	the	DET
dpc-92	167	12	dermatology	dermatology	NOUN
dpc-92	167	13	life	life	NOUN
dpc-92	167	14	quality	quality	NOUN
dpc-92	167	15	index	index	NOUN
dpc-92	167	16	(	(	PUNCT
dpc-92	167	17	dlqi	dlqi	PROPN
dpc-92	167	18	)	)	PUNCT
dpc-92	167	19	.	.	PUNCT
dpc-92	168	1	j	j	PROPN
dpc-92	168	2	invest	invest	VERB
dpc-92	168	3	dermatol	dermatol	NOUN
dpc-92	168	4	symp	symp	NOUN
dpc-92	168	5	proc	proc	NOUN
dpc-92	168	6	2004;9:169	2004;9:169	NUM
dpc-92	168	7	–	–	PUNCT
dpc-92	168	8	80	80	NUM
dpc-92	168	9	.	.	PUNCT
dpc-92	169	1	pmid	pmid	NOUN
dpc-92	169	2	:	:	PUNCT
dpc-92	169	3	15083785	15083785	NUM
dpc-92	169	4	doi	doi	NOUN
dpc-92	169	5	:	:	PUNCT
dpc-92	169	6	10.1111	10.1111	NUM
dpc-92	169	7	/	/	SYM
dpc-92	169	8	j.1087	j.1087	NOUN
dpc-92	169	9	-	-	PUNCT
dpc-92	169	10	0024.2004.09113.x	0024.2004.09113.x	NOUN
dpc-92	169	11	.	.	PUNCT